obsolete_dementia: ['An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
4 out of 7 registries used, show all original rules. |
25542 |
4. Check minimum number of events
Min. number of events
3
|
25542 |
5. Include endpoints |
25577 |
6. Filter based on genotype QC (FinnGen only) |
25577 |
Control definitions (FinnGen only)
- Control exclude
- F5_ORGANIC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF3
Dementia
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 412960 | 252777 | 155854 |
| Only index persons | 305996 | 191151 | 114845 |
| Unadjusted period prevalence (%) | |||
| Whole population | 6.12 | 7.24 | 4.35 |
| Only index persons | 6.04 | 7.03 | 4.38 |
| Median age at first event (years) | |||
| Whole population | 80.88 | 81.84 | 79.37 |
| Only index persons | 81.10 | 82.08 | 79.47 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 25577 | 11691 | 13886 |
| Unadjusted period prevalence (%) | 5.14 | 3.99 | 6.12 |
| Median age at first event (years) | 78.96 | 79.37 | 78.62 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 8380
- Matched controls
- 72221
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N06DA02
ATC
donepezil; oral
329.7
323.0
3631
167
SPAT1053
SPAT
Memory test
5.7
323.0
3937
9748
SPAT1234
SPAT
Support of social functional capacity
6.4
323.0
1038
1564
F03
ICD-10 Finland
Unspecified dementia
76.3
323.0
1729
245
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
92.4
323.0
761
78
N06DA03
ATC
rivastigmine; oral, transdermal
387.3
323.0
2257
69
A28
ICPC
Limited function/disability NOS
4.2
323.0
2740
7562
G30.1
ICD-10 Finland
Alzheimer disease with late onset
104.6
323.0
2725
331
N06DA04
ATC
galantamine; oral
367.9
323.0
988
26
SPAT1216
SPAT
Assessment of functional ability
3.6
323.0
2691
8399
F06.7
ICD-10 Finland
Mild cognitive disorder
28.6
323.0
849
283
SPAT1245
SPAT
Provision of support and information to patient’s family members
8.6
323.0
1135
1287
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
695.6
323.0
601
8
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
9.8
323.0
2462
2940
P20
ICPC
Memory disturbance
12.2
323.0
4254
5605
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
323.0
1250
*
P70
ICPC
Dementia
68.2
323.0
759
105
G30
ICD-10 Finland
Alzheimer disease
122.6
323.0
445
33
N06DX01
ATC
memantine; oral
560.3
323.0
3741
104
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
167.7
323.0
1315
80
N05AX08
ATC
risperidone; systemic
12.9
323.0
1659
1355
N05AH04
ATC
quetiapine; oral
5.2
323.0
1986
4097
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
626.0
323.0
349
5
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
151.9
323.0
1117
73
G30.0
ICD-10 Finland
Alzheimer disease with early onset
347.7
323.0
497
13
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.4
323.0
1576
2947
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
5.5
323.0
1109
1956
G30.8
ICD-10 Finland
Other Alzheimer disease
105.9
323.0
821
74
AA1AD
NOMESCO Finland
CT of head and brain
2.6
317.4
3175
13584
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.0
311.3
2249
7842
TAB00
NOMESCO Finland
Lumbar puncture
7.3
304.0
801
1032
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
1357.1
290.4
298
*
R41.3
ICD-10 Finland
Other amnesia
8.1
290.0
712
821
R53
ICD-10 Finland
Malaise and fatigue
2.8
284.4
2335
8760
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
438.8
281.3
296
6
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
6.2
271.1
805
1218
F05.9
ICD-10 Finland
Delirium, unspecified
69.2
267.4
324
42
F01.9
ICD-10 Finland
Vascular dementia, unspecified
66.2
266.6
325
44
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
248.8
2162
8282
SPAT1254
SPAT
Administration of medicine
2.8
243.4
1881
6696
G20
ICD-10 Finland
Parkinson disease
5.8
228.7
713
1140
N03AG01
ATC
valproic acid; systemic, rectal
5.3
226.0
765
1349
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
224.7
3127
15157
L28
ICPC
Limited function/disability (L)
2.6
220.9
2081
8261
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
6.1
220.3
658
995
R41.0
ICD-10 Finland
Disorientation, unspecified
7.5
218.6
561
686
XA800
NOMESCO Finland
Neuropsychological investigation
6.1
204.6
607
908
N06AX11
ATC
mirtazapine; oral
2.1
192.0
2942
14625
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
51.7
175.3
222
38
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
273.7
172.1
185
6
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
+∞
167.8
170
*
N87
ICPC
Parkinsonism
9.1
167.5
377
370
N05BA04
ATC
oxazepam; oral
2.1
163.2
2282
10737
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.1
162.8
1005
3008
N05AH03
ATC
olanzapine; systemic
4.8
162.6
593
1124
F05.1
ICD-10 Finland
Delirium superimposed on dementia
+∞
158.8
161
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
157.9
1503
5860
SPAT1229
SPAT
Assessment of need for aid
2.8
156.2
1130
3752
N06AB10
ATC
escitalopram; oral
2.5
154.4
1447
5589
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
11.8
147.0
289
218
A04
ICPC
Weakness/tiredness general
2.4
140.8
1384
5453
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.9
135.5
936
3001
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.0
135.4
474
856
N06AX26
ATC
vortioxetine; oral
4.7
134.9
498
952
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
131.6
764
2169
WYA20
NOMESCO Finland
Home visit
10.6
131.2
271
226
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.7
126.7
615
1518
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
1139.5
126.1
130
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.1
123.3
758
2239
A06AD11
ATC
lactulose; oral
2.2
122.8
1501
6530
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
7.7
122.4
304
350
N04BD01
ATC
selegiline; oral
7.4
119.7
307
371
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
117.3
119
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.0
117.1
1839
8873
SPAT1301
SPAT
No procedures
1.8
116.6
3210
18835
SPAT1172
SPAT
Guidance concerning hydration
5.2
115.7
386
659
SPAT1101
SPAT
Orthostatic test
3.2
115.2
687
1982
SPAT1304
SPAT
Counselling and guidance related to ageing
2.5
114.9
1054
3971
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
30.5
113.7
160
46
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
9.1
113.0
253
245
N05BA06
ATC
lorazepam; systemic, sublingual
3.4
110.2
596
1599
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.7
109.8
847
2890
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.1
109.3
1412
6261
G31.0
ICD-10 Finland
Circumscribed brain atrophy
21.6
106.6
165
67
U04
ICPC
Incontinence urine
3.1
104.5
639
1872
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.0
102.9
664
2017
SPAT1252
SPAT
Overall medication plan or its review
2.5
102.2
892
3259
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
101.3
2200
11837
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.2
100.3
413
877
N05AD01
ATC
haloperidol; systemic
4.8
98.2
351
646
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
229.5
96.9
105
*
I95.1
ICD-10 Finland
Orthostatic hypotension
3.6
96.8
484
1218
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
96.4
1313
5924
N06AB04
ATC
citalopram; systemic
1.9
95.5
1746
8823
F05.8
ICD-10 Finland
Other delirium
133.3
95.1
107
7
S01.0
ICD-10 Finland
Open wound of scalp
2.6
93.6
775
2743
SPAT1360
SPAT
Extensive global examination
2.4
91.2
907
3537
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.5
89.2
805
2983
A29
ICPC
General symptom/complaint other
2.1
88.3
1164
5163
S06.0
ICD-10 Finland
Concussion
2.3
88.2
906
3586
109
Kela drug reimbursment
Multiple sclerosis
14.5
88.1
157
95
N04BD02
ATC
rasagiline; oral
9.2
87.1
193
184
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.3
86.8
485
1328
G35
ICD-10 Finland
Multiple sclerosis
8.6
86.5
200
205
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
394.6
86.1
91
*
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
269.1
85.6
92
*
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
44.8
83.5
108
21
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.5
82.8
317
626
W19
ICD-10 Finland
Unspecified fall
2.3
82.5
887
3582
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
20.7
81.8
128
54
S72.0
ICD-10 Finland
Fracture of neck of femur
3.4
81.5
426
1109
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
80.1
1306
6282
SPAT1246
SPAT
Screening of depression or other psychiatric problem
4.4
79.7
313
634
R55
ICD-10 Finland
Syncope and collapse
2.0
78.8
1145
5262
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
78.4
1532
19897
F01.2
ICD-10 Finland
Subcortical vascular dementia
44.0
77.9
101
20
G04BD12
ATC
mirabegron; oral
1.9
77.0
1265
6092
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
6.0
75.2
221
323
F00
ICD-10 Finland
Dementia in Alzheimer disease
46.4
74.8
96
18
SPAT1167
SPAT
Insertion of urinary catheter
3.0
72.9
449
1317
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
4.7
71.6
262
494
193
Kela drug reimbursment
Rasagiline
9.3
70.1
154
145
R42
ICD-10 Finland
Dizziness and giddiness
1.6
69.9
2097
12178
AXX01
SPAT
NA
4.9
69.7
245
443
N03AE01
ATC
clonazepam; systemic
2.5
68.2
574
2039
F21
ICPC
NA
9.2
67.6
149
141
Z02.7
ICD-10 Finland
Issue of medical certificate
2.5
67.6
573
2043
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.0
67.0
1036
4859
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.8
66.9
238
436
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.5
65.2
250
495
N04BC04
ATC
ropinirole; oral
5.4
64.1
207
340
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
63.7
2909
18652
SPAT1139
SPAT
Nutrition survey
3.2
63.4
359
991
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
63.1
690
2792
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.0
62.3
960
4486
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.5
61.0
507
1784
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
528.0
58.3
61
*
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
18.6
58.3
94
44
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
8.0
58.0
139
152
N06AB06
ATC
sertraline; oral
2.1
58.0
702
2971
N03AX14
ATC
levetiracetam; systemic
3.5
57.9
290
729
L03AB07
ATC
interferon beta-1a; parenteral
24.1
57.8
86
31
F01
ICD-10 Finland
Vascular dementia
25.2
57.2
84
29
N02BE01
ATC
paracetamol; systemic, rectal
1.7
56.9
7251
57353
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.1
56.5
234
499
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.7
56.3
204
381
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.1
56.3
718
3106
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.1
55.4
230
492
SPAT1263
SPAT
Sampling
1.4
55.0
3618
24823
N06AX16
ATC
venlafaxine; oral
1.9
54.0
838
3912
N29
ICPC
Neurological sympt/complt other
3.7
53.8
251
595
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.9
53.8
836
3908
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
105.9
53.3
61
5
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.9
53.1
917
4448
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
53.0
1394
7717
N86
ICPC
Multiple sclerosis
11.3
52.7
104
80
F0019, G301
ICD-10 Finland
NA
+∞
52.2
53
*
N02AA05
ATC
oxycodone; systemic
1.7
52.1
1358
7499
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.8
51.3
356
1126
F009, G309
ICD-10 Finland
NA
+∞
51.2
52
*
N30.0
ICD-10 Finland
Acute cystitis
1.7
50.3
1166
6215
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
49.5
1380
7747
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
48.8
1017
5244
N03AF02
ATC
oxcarbazepine; oral
3.1
48.3
287
820
N05AA02
ATC
levomepromazine; systemic
2.8
48.3
338
1075
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.3
48.0
265
718
N04BX02
ATC
entacapone; oral
13.9
47.4
85
53
N03AX09
ATC
lamotrigine; oral
3.2
47.4
263
716
N28
ICPC
Limited function/disability (N)
3.9
47.2
206
462
L03AX13
ATC
glatiramer acetate; parenteral
25.7
46.7
68
23
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.4
46.4
426
1577
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
216.8
46.2
50
*
N04AA02
ATC
biperiden; systemic
4.1
45.2
189
408
C03CA01
ATC
furosemide; systemic
1.4
45.0
2654
17614
P29
ICPC
Psychological sympt/compl other
2.8
44.9
304
947
N06AX21
ATC
duloxetine; oral
1.9
44.7
731
3469
E86
ICD-10 Finland
Volume depletion
3.3
43.6
235
626
N04BC05
ATC
pramipexole; oral
1.9
43.6
707
3346
F10.73
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol dementia
26.9
43.2
62
20
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
43.2
2658
17747
Z75.5
ICD-10 Finland
Holiday relief care
11.5
42.5
83
63
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.4
42.4
162
321
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
42.4
2652
17748
N99
ICPC
Neurological disease other
4.4
42.1
160
315
S70.0
ICD-10 Finland
Contusion of hip
2.6
41.2
326
1115
F22.0
ICD-10 Finland
Delusional disorder
4.4
41.1
156
307
SPAT1050
SPAT
Extensive neurological examination
3.0
40.8
250
730
SPAT1262
SPAT
Handing over of treatment supplies
1.5
39.9
1725
10696
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.2
39.4
417
1656
T90.5
ICD-10 Finland
Sequelae of intracranial injury
5.3
39.3
126
207
R44.1
ICD-10 Finland
Visual hallucinations
11.6
39.2
76
57
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
31.2
39.1
54
15
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.9
39.1
655
3131
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.8
38.6
702
3451
130
Kela drug reimbursment
Malignant tumour
0.5
38.5
249
4512
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
38.5
439
1803
N27
ICPC
Fear of neurological disease other
3.6
38.2
183
445
C10AA01
ATC
simvastatin; oral
1.4
38.1
4426
32694
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
4.3
37.5
147
299
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.7
37.5
783
4024
R11
ICD-10 Finland
Nausea and vomiting
1.9
37.4
615
2919
H02AB02
ATC
dexamethasone; systemic
0.5
37.2
308
5159
N05AH02
ATC
clozapine; systemic
5.4
36.8
116
187
F06.0
ICD-10 Finland
Organic hallucinosis
335.7
36.8
39
*
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
335.7
36.8
39
*
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
74.5
36.3
43
5
R1250
NOMESCO Finland
Evaluation of functional capability
3.3
36.0
191
504
J01CA08
ATC
pivmecillinam; oral
1.4
35.8
2646
18104
F02.09
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
35.4
36
*
R25.1
ICD-10 Finland
Tremor, unspecified
2.5
35.4
302
1078
K90
ICPC
Stroke/cerebrovascular accident
2.4
34.9
307
1112
Z29
ICPC
Social problem NOS
3.8
34.9
156
359
N04BB01
ATC
amantadine; oral
3.5
34.7
170
422
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.8
34.6
610
2963
SPAT1279
SPAT
Preparation of immediate hospitalisation
4.7
34.5
123
228
J01EA01
ATC
trimethoprim; systemic
1.4
34.5
1874
12117
F01.24
ICD-10 Finland
Subcortical vascular dementia other additional symptoms of mixed type
+∞
34.4
35
*
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
4.0
34.3
143
309
R33
ICD-10 Finland
Retention of urine
1.7
34.2
739
3834
N05AB03
ATC
perphenazine; systemic, rectal
2.6
34.1
268
915
F01.0
ICD-10 Finland
Vascular dementia of acute onset
309.5
33.9
36
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
33.9
584
2817
R32
ICD-10 Finland
Unspecified urinary incontinence
2.5
33.8
287
1020
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.5
33.3
163
405
Z01.9
ICD-10 Finland
Special examination, unspecified
1.9
33.2
493
2253
G40
ICD-10 Finland
Epilepsy
5.3
33.1
105
171
SPAT1260
SPAT
Consultation of another employee
1.5
33.1
1547
9700
F001, G301
ICD-10 Finland
NA
300.7
32.9
35
*
N04BC09
ATC
rotigotine; transdermal
7.6
32.9
80
91
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.7
32.9
149
347
164
Kela drug reimbursment
Fingolimod
82.2
32.5
38
*
N05AN01
ATC
lithium; oral
3.4
32.4
164
418
S06.3
ICD-10 Finland
Focal brain injury
4.0
32.4
135
292
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
32.1
1048
6068
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
32.1
1300
7903
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
32.0
916
5132
K59.09
ICD-10 Finland
Constipation, unspecified
1.8
32.0
570
2778
G41.9
ICD-10 Finland
Status epilepticus, unspecified
7.3
32.0
80
95
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
3.4
31.9
160
405
N19
ICPC
Speech disorder
3.6
31.9
151
365
N05BA01
ATC
diazepam; systemic, rectal
1.6
31.8
1005
5771
N05AX12
ATC
aripiprazole; systemic
3.5
31.8
157
393
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.0
31.6
195
574
F0009, G300
ICD-10 Finland
NA
+∞
31.5
32
*
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
283.3
31.0
33
*
SPAT1307
SPAT
Psychosocial counselling and guidance
2.5
30.6
249
865
M03BX01
ATC
baclofen; systemic
3.4
30.6
156
401
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
+∞
30.5
31
*
F01.34
ICD-10 Finland
Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type
+∞
30.5
31
*
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.6
30.4
144
349
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
30.4
327
1309
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.2
30.3
167
455
SPAT1125
SPAT
Stoma care and guidance
3.0
30.1
180
519
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.1
29.7
171
480
353
Kela drug reimbursment
Cladribine and fingolimod
98.0
29.7
34
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.5
29.4
143
354
N03AX18
ATC
lacosamide; systemic
6.4
29.4
80
108
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
5.8
29.3
86
128
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.9
29.1
479
2272
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.7
29.0
133
314
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.1
28.9
326
1334
183
Kela drug reimbursment
Lamotrigin and topiramate
6.0
28.7
82
118
F02.89*E03.9
ICD-10 Finland
Dementia in hypothyroidism, acquired
+∞
28.5
29
*
SPAT1251
SPAT
Organisation of medication
2.2
28.2
297
1175
N05CD07
ATC
temazepam; oral
1.5
28.2
1004
5919
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.0
28.1
399
1793
A10AE04
ATC
insulin glargine; parenteral
1.6
28.0
752
4138
G04BD04
ATC
oxybutynin; oral, transdermal
1.8
27.9
478
2300
K59.0
ICD-10 Finland
Constipation
1.9
27.8
462
2198
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
3.5
27.5
136
342
P99
ICPC
Psychological disorders other
3.3
27.5
143
374
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.9
27.3
172
514
G72.8
ICD-10 Finland
Other specified myopathies
3.2
27.1
148
401
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
129.7
26.9
30
*
G04BD08
ATC
solifenacin; oral
1.7
26.7
649
3477
N30.9
ICD-10 Finland
Cystitis, unspecified
1.9
26.6
422
1976
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.1
26.6
310
1287
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
10.7
26.6
53
43
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
8.0
26.5
62
67
N17
ICPC
Vertigo/dizziness
1.5
26.4
986
5869
L82
ICD-10 Finland
Seborrhoeic keratosis
0.7
26.3
738
9193
L03AB08
ATC
interferon beta-1b; parenteral
18.2
26.3
42
20
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
243.1
26.1
28
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.4
26.1
82
1960
F01.80
ICD-10 Finland
Other specified vascular dementia without additional symptoms
55.3
26.1
32
5
K08.3
ICD-10 Finland
Retained dental root
1.7
26.0
539
2756
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.8
26.0
170
521
R63.4
ICD-10 Finland
Abnormal weight loss
2.0
25.9
334
1445
N88
ICPC
Epilepsy
6.6
25.9
69
91
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
4.3
25.6
99
201
H02AA02
ATC
fludrocortisone; oral
4.9
25.6
86
151
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
+∞
25.6
26
*
H46
ICD-10 Finland
Optic neuritis
6.3
25.5
70
96
N18
ICPC
Paralysis/weakness
2.6
25.4
197
668
A04AA02
ATC
granisetron; systemic, transdermal
0.5
25.4
158
2905
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
25.3
1792
12036
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.7
25.1
706
8796
A01
ICPC
Pain general/multiple sites
1.7
25.0
602
3211
F00.24
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
121.0
25.0
28
*
W06
ICD-10 Finland
Fall involving bed
5.0
25.0
83
144
F10.24
ICD-10 Finland
Alcohol depence active use
4.2
24.8
99
207
S00.0
ICD-10 Finland
Superficial injury of scalp
2.7
24.7
179
585
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
24.6
614
3309
A27
ICPC
Fear of other disease NOS
1.9
24.6
384
1787
R35
ICD-10 Finland
Polyuria
1.7
24.6
578
3063
N03AF01
ATC
carbamazepine; oral, rectal
1.9
24.3
389
1828
WX402
NOMESCO Finland
General anaesthesia
0.6
24.2
590
7567
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.6
24.2
709
3984
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.4
24.1
92
2031
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
2.5
23.8
191
662
F0014, G301
ICD-10 Finland
NA
+∞
23.6
24
*
F00, F03
ICD-10 Finland
NA
+∞
23.6
24
*
P05
ICPC
Senility, feeling/behaving old
6.9
23.4
60
75
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
4.0
23.4
96
207
P28
ICPC
Limited function/disability (P)
5.9
23.3
67
98
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
3.1
23.3
135
383
SPAT1138
SPAT
Guidance concerning bowel function
3.1
23.3
135
383
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
216.1
23.2
25
*
L04AA27
ATC
fingolimod; oral
60.6
23.2
28
*
Z28
ICPC
Limited function/disability (Z)
6.3
23.1
63
86
R44.3
ICD-10 Finland
Hallucinations, unspecified
7.5
23.0
56
65
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.4
23.0
204
747
AA1AA
NOMESCO Finland
Head X-ray examination
3.7
22.7
103
243
SPAT1240
SPAT
Therapeutic discussion
1.7
22.6
495
2568
R1250
SPAT
NA
5.2
22.5
72
120
K91
ICPC
Cerebrovascular disease
2.8
22.5
150
467
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
22.4
512
2692
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.8
22.3
1592
17123
Y94.0
ICD-10 Finland
Accident at home
2.7
22.3
157
506
SPAT1281
SPAT
Other administrative function
1.6
22.3
630
3509
D21
ICPC
Swallowing problem
2.9
22.2
143
435
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.4
22.1
203
754
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.6
22.1
162
533
F32
ICD-10 Finland
Depressive episode
2.1
21.9
250
1027
SPAT1236
SPAT
Informing family of child’s disability
2.3
21.8
204
766
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
7.6
21.7
52
59
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.6
21.7
78
148
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.3
21.7
200
744
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.1
21.7
260
1094
F00.01
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism
+∞
21.6
22
*
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
+∞
21.6
22
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
5.0
21.6
72
126
N03AB02
ATC
phenytoin; systemic
3.5
21.4
105
264
XF606
NOMESCO Finland
Ortostatic test
3.7
21.3
95
221
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
8.7
21.2
47
47
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
21.2
1944
13518
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.4
21.2
106
271
G04BD09
ATC
trospium; oral
2.1
21.1
249
1041
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
7.3
21.0
52
62
N05AD03
ATC
melperone; systemic
4.2
21.0
83
173
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.6
21.0
510
2728
P03
ICPC
Feeling depressed
1.8
20.9
370
1797
L01BC06
ATC
capecitabine; oral
0.4
20.9
70
1625
G91.0
ICD-10 Finland
Communicating hydrocephalus
5.3
20.8
65
106
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.2
20.8
218
865
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
4.0
20.7
85
184
P15
ICPC
Chronic alcohol abuse
2.6
20.7
158
534
M01AH05
ATC
etoricoxib; oral
0.8
20.7
3187
31352
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
20.5
1270
8304
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
23.6
20.5
30
11
F06.8
ICD-10 Finland
Other specified mental disorders due to brain damage and dysfunction and to physical disease
190.0
20.3
22
*
SPAT1127
SPAT
Enema
3.7
20.3
91
213
Z13.3
ICD-10 Finland
Special screening examination for mental and behavioural disorders
14.4
20.3
35
21
L57.0
ICD-10 Finland
Actinic keratosis
0.7
20.3
521
6621
F02.80
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without additional symptoms
99.3
20.2
23
*
F20.9
ICD-10 Finland
Schizophrenia, unspecified
2.9
20.2
127
381
N06AX12
ATC
bupropion; oral
2.2
20.2
204
797
SPAT1284
SPAT
Extensive health certificate
2.3
20.1
196
752
N05CF01
ATC
zopiclone; oral
1.3
19.9
2432
17541
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
3.5
19.9
95
234
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.9
19.9
281
1263
F0011, G301
ICD-10 Finland
NA
+∞
19.7
20
*
F01.1
ICD-10 Finland
Multi-infarct dementia
+∞
19.7
20
*
F00.09
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking
+∞
19.7
20
*
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.9
19.6
296
1364
F01.23
ICD-10 Finland
Subcortical vascular dementia other additional symptoms, mainly depression
51.8
19.5
24
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
19.4
3135
23371
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
4.5
19.4
70
134
G04BD07
ATC
tolterodine; oral
1.7
19.4
424
2202
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
4.8
19.4
66
119
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
8.9
19.3
42
41
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.4
19.2
95
241
P76
ICPC
Depressive disorder
2.0
19.2
260
1149
A69
ICPC
General and Unspecified, Other reason for encounter NEC
2.3
19.1
189
730
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
5.9
19.0
54
79
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
4.7
18.9
66
122
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.8
18.8
317
1517
A10BB01
ATC
glibenclamide; oral
1.9
18.8
307
1452
B03BA03
ATC
hydroxocobalamin; parenteral
1.6
18.8
467
2516
SPAT1310
SPAT
Counselling related to known health issue
1.3
18.7
2592
18957
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.9
18.6
268
1213
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.3
18.5
183
708
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.8
18.5
125
393
F02.89
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without information of additional symptoms
23.3
18.5
27
10
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
3.9
18.5
78
174
F00.12
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations
172.7
18.4
20
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
18.4
1979
14018
L75
ICPC
Fracture: femur
2.9
18.4
116
350
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
10.7
18.4
36
29
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
18.2
566
3222
Z51.88
ICD-10 Finland
Other specified medical care
2.3
18.2
169
635
SPAT1285
SPAT
Provision of consultation response
1.6
18.1
446
2393
AA1AD
SPAT
NA
9.4
18.1
38
35
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.2
18.0
98
268
A03FA01
ATC
metoclopramide; systemic, rectal
0.7
18.0
945
10654
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.4
18.0
74
1580
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.3
17.9
1289
8619
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
2.9
17.8
110
328
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
9.1
17.8
38
36
L04AA31
ATC
teriflunomide; oral
27.0
17.8
25
8
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
3.1
17.8
101
284
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
4.2
17.7
69
143
F0232, G20
ICD-10 Finland
NA
+∞
17.7
18
*
S09.9
ICD-10 Finland
Unspecified injury of head
3.1
17.6
98
273
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
17.6
1575
10874
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.5
17.6
83
204
OAB43
SPAT
NA
0.3
17.5
45
1174
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
17.3
17.5
28
14
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.9
17.4
252
1144
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.7
17.4
357
1821
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
2.1
17.3
201
836
S22.3
ICD-10 Finland
Fracture of rib
1.6
17.3
472
2601
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.5
17.2
663
3959
WX212
NOMESCO Finland
Femoral plexus blockade
2.3
17.2
165
631
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
2.9
17.1
108
325
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
2.7
17.1
119
383
N07BB01
ATC
disulfiram; oral
2.1
17.1
210
893
XF606
SPAT
NA
7.7
17.0
40
45
EBA30
NOMESCO Finland
Excision of root of tooth
1.6
16.9
409
2185
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.5
16.7
80
199
SPAT1014
SPAT
Treatment of eyes
2.4
16.7
149
550
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
3.7
16.6
74
174
S97
ICPC
Chronic ulcer skin
1.6
16.6
455
2515
Z03
ICPC
Housing/neighbourhood problem
4.8
16.6
56
101
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
9.2
16.5
35
33
S28
ICPC
Limited function/disability (S)
4.4
16.5
60
117
G46.8*I67.9
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
10.2
16.5
33
28
SPAT1244
SPAT
Occupational therapy
3.0
16.5
99
289
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
2.9
16.4
104
316
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
10.6
16.3
32
26
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.0
16.3
95
274
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
4.2
16.2
62
127
A10BB12
ATC
glimepiride; oral
1.5
16.2
600
3557
N05BA09
ATC
clobazam; oral
6.6
16.1
42
55
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
16.1
740
4577
L76
ICPC
Fracture: other
2.0
16.1
218
967
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
4.1
16.1
63
132
Z60.8
ICD-10 Finland
Other problems related to social environment
11.8
16.1
30
22
B01AC04
ATC
clopidogrel; oral
1.3
16.1
1462
10101
R13
ICD-10 Finland
Dysphagia
1.5
16.0
495
2814
N05AC02
ATC
thioridazine; oral
2.5
16.0
129
453
A10AE05
ATC
insulin detemir; parenteral
1.7
15.9
373
1975
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.9
15.8
244
1135
N05AF03
ATC
chlorprothixene; systemic
2.3
15.8
148
560
F00.04
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type
+∞
15.7
16
*
F00.13
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression
+∞
15.7
16
*
UKC02
NOMESCO Finland
Cystoscopy
1.3
15.7
1437
9933
F01.39
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without information on additional symptoms
54.6
15.6
19
*
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
4.0
15.6
63
136
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
2.5
15.5
125
436
F01.8
ICD-10 Finland
Other vascular dementia
77.7
15.5
18
*
F09
ICD-10 Finland
Unspecified organic or symptomatic mental disorder
146.7
15.5
17
*
2AB04
NOMESCO Finland
NA
10.8
15.5
30
24
N04BC02
ATC
pergolide; oral
16.6
15.4
25
13
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.5
15.4
73
181
N05AF05
ATC
zuclopenthixol; systemic
3.6
15.4
70
168
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
15.2
1840
13179
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.0
15.2
187
800
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
1.7
15.1
309
1575
G40.89
ICD-10 Finland
Other epilepsy
5.7
15.1
44
67
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.2
15.1
2715
20314
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
4.7
15.1
52
96
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.3
15.1
146
561
Z11
ICPC
Compliance/being ill problem
4.2
15.1
58
120
I50.9
ICD-10 Finland
Heart failure, unspecified
1.3
15.0
1027
6800
N03AX11
ATC
topiramate; oral
2.8
15.0
98
305
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
3.8
14.9
64
146
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.6
14.9
69
168
I95.9
ICD-10 Finland
Hypotension, unspecified
2.5
14.9
119
416
F01.84
ICD-10 Finland
Other specified vascular dementia other mixed symptoms of mixed type
+∞
14.7
15
*
F0024, G308
ICD-10 Finland
NA
+∞
14.7
15
*
F00.21
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism
+∞
14.7
15
*
F00.2
ICD-10 Finland
Dementia in Alzheimer disease, atypical or mixed type
+∞
14.7
15
*
4378X
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Other[MORBUS CERBROVASCULARIS ALIA DEFINITA]
+∞
14.7
15
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.8
14.7
282
1408
E87.6
ICD-10 Finland
Hypokalaemia
1.8
14.7
238
1124
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
51.8
14.7
18
*
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
4.2
14.7
56
115
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
4.3
14.7
55
111
F99
ICD-10 Finland
Mental disorder, not otherwise specified
2.8
14.6
94
289
F01.33
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly depression
138.1
14.5
16
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.0
14.5
189
827
D12
ICPC
Constipation
1.7
14.5
275
1373
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
3.1
14.4
79
219
N06AA09
ATC
amitriptyline; systemic
1.4
14.4
735
4632
S06.2
ICD-10 Finland
Diffuse brain injury
3.3
14.4
74
196
N05BE01
ATC
buspirone; oral
2.0
14.4
174
739
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.8
14.4
921
10124
N06AX03
ATC
mianserin; oral
1.7
14.3
334
1771
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.6
14.2
354
1910
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
4.0
14.1
57
124
L04AX07
ATC
dimethyl fumarate; oral
24.7
14.0
20
7
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
0.5
14.0
93
1670
U28
ICPC
Limited function/disability (U)
2.7
14.0
96
309
H04AA01
ATC
glucagon; nasal, parenteral
2.7
13.9
94
298
F06.32
ICD-10 Finland
Organic depression
13.8
13.9
24
15
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
3.1
13.9
79
224
SPAT1243
SPAT
Psychiatric/psychological examination
2.7
13.8
97
313
T08
ICPC
Weight loss
2.4
13.8
121
444
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
0.4
13.8
73
1416
F06.30
ICD-10 Finland
Organic manic syndrome
+∞
13.8
14
*
Z51.5
ICD-10 Finland
Palliative care
1.5
13.7
516
3066
N80
ICPC
Head injury other
2.3
13.7
125
466
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
3.0
13.7
81
237
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.9
13.7
56
123
R5110
SPAT
NA
1.9
13.7
214
1001
B01AA03
ATC
warfarin; systemic
1.3
13.7
1718
12337
Q90.9
ICD-10 Finland
Down syndrome, unspecified
69.1
13.6
16
*
LAITO
NOMESCO Finland
NA
69.1
13.6
16
*
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
1.9
13.6
214
1004
S01.8
ICD-10 Finland
Open wound of other parts of head
2.7
13.6
96
312
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
2.4
13.6
116
419
R60.0
ICD-10 Finland
Localized oedema
1.3
13.6
894
5881
F07.8
ICD-10 Finland
Other organic personality and behavioural disorders due to brain disease, damage and dysfunction
129.4
13.6
15
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.5
13.5
410
2325
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
5.9
13.3
37
54
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.7
13.2
290
1512
W10
ICD-10 Finland
Fall on and from stairs and steps
1.6
13.2
329
1775
N02AJ06
ATC
codeine and paracetamol; systemic
0.8
13.2
1981
19804
R47.0
ICD-10 Finland
Dysphasia and aphasia
2.9
13.1
82
249
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.5
13.1
89
1589
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
13.1
866
5700
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
13.1
363
2011
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.8
13.0
56
129
WF002
NOMESCO Finland
Radical radiotherapy
0.6
13.0
202
2864
HA1RA
SPAT
NA
0.2
13.0
18
637
N06AB03
ATC
fluoxetine; oral
1.4
12.9
762
4925
359
Kela drug reimbursment
Mirabegroni
3.2
12.9
69
189
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.1
12.8
138
560
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
4.6
12.8
44
82
E0000UV
ATC
NA
1.2
12.8
2677
20253
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
4.0
12.8
51
110
F02.89*A69.2
ICD-10 Finland
Dementia in Lyme disease
+∞
12.8
13
*
F00.23
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression
+∞
12.8
13
*
XA400
NOMESCO Finland
EEG
3.8
12.8
54
123
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
12.7
773
5023
F00.29
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms
120.8
12.6
14
*
S20.2
ICD-10 Finland
Contusion of thorax
1.6
12.6
297
1578
R2110
NOMESCO Finland
Giving the first information
1.5
12.6
389
2214
N07XX09
ATC
[U] dimethyl fumarate; oral
29.3
12.5
17
5
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
6.3
12.5
33
45
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
4.9
12.5
41
73
SPAT1104
SPAT
Monitoring of emergency patient
1.4
12.4
512
3101
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.6
12.4
340
1879
SPAT1255
SPAT
Intravenous administration of medicine
1.5
12.3
495
2982
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
4.0
12.3
49
106
S00.8
ICD-10 Finland
Superficial injury of other parts of head
2.5
12.3
99
350
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.4
12.3
715
4611
F31
ICD-10 Finland
Bipolar affective disorder
3.8
12.2
52
119
IHZ08
SPAT
NA
34.5
12.2
16
*
Z43.5
ICD-10 Finland
Attention to cystostomy
3.8
12.2
51
115
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.6
12.2
191
2701
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
2.2
12.2
118
457
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.2
12.1
2024
14958
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.7
12.1
274
1443
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
8.6
12.1
26
26
C01DA14
ATC
isosorbide mononitrate; oral
1.3
12.1
1275
8954
U13
ICPC
Bladder symptom/complaint other
1.7
12.0
231
1159
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.2
12.0
126
505
F34.1
ICD-10 Finland
Dysthymia
2.0
11.9
158
698
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
4.7
11.9
40
73
A86
ICD-10 Finland
Unspecified viral encephalitis
4.3
11.9
44
89
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.9
11.8
183
854
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.8
11.8
1693
17041
A46
ICD-10 Finland
Erysipelas
1.3
11.8
1060
7286
R51.80
ICD-10 Finland
Headache
1.3
11.8
775
5095
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
11.8
12
*
F0029, G308
ICD-10 Finland
NA
+∞
11.8
12
*
F0004, G300
ICD-10 Finland
NA
+∞
11.8
12
*
F009, F03
ICD-10 Finland
NA
+∞
11.8
12
*
R40.2
ICD-10 Finland
Coma, unspecified
3.0
11.8
69
202
R74
ICPC
Upper respiratory infection acute
0.8
11.8
871
9420
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.6
11.8
259
3398
S82
ICPC
Naevus/mole
0.7
11.8
521
6047
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
3.4
11.7
57
146
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
3.5
11.7
55
137
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
3.8
11.7
49
111
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
11.7
2143
15975
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
6.0
11.7
32
46
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.8
11.7
197
948
N06AB05
ATC
paroxetine; oral
1.6
11.7
307
1681
A23
ICPC
Risk factor NOS
1.6
11.7
310
1701
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
11.6
448
2675
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.8
11.6
2295
22440
Z08
ICPC
Social welfare problem
3.0
11.6
67
194
S20
ICPC
Corn/callosity
1.9
11.5
173
801
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.0
11.5
153
678
A10AA02
ATC
NA
1.9
11.5
161
727
S06.9
ICD-10 Finland
Intracranial injury, unspecified
3.6
11.5
51
122
R47.1
ICD-10 Finland
Dysarthria and anarthria
2.7
11.4
79
255
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
11.4
761
5012
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
0.3
11.4
18
596
P01
ICPC
Feeling anxious/nervous/tense
1.6
11.4
312
1728
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.5
11.3
437
2612
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.5
11.3
111
1770
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.4
11.3
618
3943
-1
ICPC
NA
2.0
11.2
144
629
E000001
ATC
NA
1.3
11.2
1249
8818
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.6
11.2
82
275
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
4.9
11.2
36
63
N06BA07
ATC
modafinil; oral
8.6
11.2
24
24
P72
ICPC
Schizophrenia
2.6
11.2
83
282
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
11.2
1204
8470
-2
ICPC
NA
4.0
11.1
44
95
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
7.5
11.1
26
30
RT150
NOMESCO Finland
NA
10.0
11.1
22
19
F01.21
ICD-10 Finland
Subcortical vascular dementia without additional symptoms, mainly paranoidism
40.2
11.1
14
*
AA1XD
NOMESCO Finland
Other special CT of head and brain
4.0
11.0
44
96
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
4.1
11.0
42
88
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
4.2
11.0
41
84
I68.0
ICD-10 Finland
Cerebral amyloid angiopathy
10.7
11.0
21
17
WZC30
NOMESCO Finland
Teaching
0.8
10.9
646
7196
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.6
10.9
251
1328
Y07
ICD-10 Finland
Other maltreatment
5.3
10.9
33
54
A04AA01
ATC
ondansetron; systemic, rectal
0.6
10.9
227
3011
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.8
10.9
68
208
Z72.1
ICD-10 Finland
Alcohol use
2.8
10.9
70
219
F02.89*M32.8
ICD-10 Finland
Dementia in systemic lupus erythematosus
+∞
10.8
11
*
F02.04
ICD-10 Finland
Dementia in Pick's disease other additional symptoms of mixed type
+∞
10.8
11
*
F0200, G310
ICD-10 Finland
NA
+∞
10.8
11
*
F0023, G308
ICD-10 Finland
NA
+∞
10.8
11
*
F0203, G310
ICD-10 Finland
NA
+∞
10.8
11
*
F06.33
ICD-10 Finland
Organic mood syndrome
+∞
10.8
11
*
F00.22
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations
+∞
10.8
11
*
F02.82
ICD-10 Finland
Dementia in other specified disease that is classified elsewhere other symptoms, mainly hallucinations
+∞
10.8
11
*
F07.0
ICD-10 Finland
Organic personality disorder
+∞
10.8
11
*
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.3
10.8
683
4461
4AA23
NOMESCO Finland
NA
25.9
10.8
15
5
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
5.2
10.8
33
55
AA1CG
SPAT
NA
3.5
10.8
49
120
R45.1
ICD-10 Finland
Restlessness and agitation
8.6
10.7
23
23
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
0.6
10.7
210
2824
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.9
10.7
64
191
IGP01
NOMESCO Finland
Psychiatric family contact
6.7
10.7
27
35
S01
ICD-10 Finland
Open wound of head
2.4
10.7
88
314
Z75.0
ICD-10 Finland
Medical services not available in home
8.0
10.7
24
26
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.2
10.7
107
420
D64.9
ICD-10 Finland
Anaemia, unspecified
1.3
10.7
770
5131
Y94.1
ICD-10 Finland
Accident in connection with service housing
16.3
10.6
17
9
S80.0
ICD-10 Finland
Contusion of knee
1.5
10.6
344
1981
G04BD11
ATC
fesoterodine; oral
1.6
10.6
259
1395
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
2.6
10.5
75
249
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
0.7
10.5
262
3357
C10AA05
ATC
atorvastatin; oral
1.2
10.5
3523
27644
F07.2
ICD-10 Finland
Postconcussional syndrome
30.2
10.5
14
*
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
1.9
10.4
150
687
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
3.0
10.4
59
169
T05
ICPC
Feeding problem of adult
3.4
10.4
49
124
EBA00
NOMESCO Finland
Extraction of tooth
1.2
10.4
2121
15949
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.4
10.3
536
3388
N05AL01
ATC
sulpiride; systemic
2.2
10.3
107
428
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
3.9
10.3
41
90
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
2.9
10.2
61
182
N05BA02
ATC
chlordiazepoxide; systemic
1.9
10.2
154
715
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
2.4
10.2
82
290
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
3.8
10.2
43
99
SPAT1107
SPAT
Extensive external surface anaesthesia of skin with cream or gel
5.0
10.2
32
55
188
Kela drug reimbursment
Psychosis requiring demanding treatment
3.1
10.2
54
149
A04AA55
ATC
palonosetron, combinations; systemic
0.4
10.1
34
785
G04CA02
ATC
tamsulosin; oral
1.2
10.1
1965
14705
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.5
10.0
79
278
Z50.1
ICD-10 Finland
Other physical therapy
1.5
10.0
389
2333
N04BC06
ATC
cabergoline; oral (dopamine agonists)
4.0
10.0
39
84
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
2.6
10.0
70
229
RS222
NOMESCO Finland
NA
2.4
9.9
81
290
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
0.5
9.9
62
1131
S01.9
ICD-10 Finland
Open wound of head, part unspecified
2.1
9.9
109
447
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.2
9.9
99
389
D17
ICPC
Incontinence of bowel
2.5
9.9
74
253
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
1.6
9.9
277
1546
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
0.4
9.9
45
917
F002, G308
ICD-10 Finland
NA
+∞
9.8
10
*
F0024, G301
ICD-10 Finland
NA
+∞
9.8
10
*
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
+∞
9.8
10
*
2900A
ICD-9 Finland
Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated
+∞
9.8
10
*
F02.00
ICD-10 Finland
Dementia in Pick's disease without additional symptoms
+∞
9.8
10
*
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
3.0
9.8
56
161
D07AA02
ATC
hydrocortisone; topical
1.3
9.8
723
4834
L03AA02
ATC
filgrastim; parenteral
0.5
9.8
58
1080
F02.8
ICD-10 Finland
Dementia in other specified diseases classified elsewhere
94.9
9.8
11
*
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
5.3
9.8
29
47
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
4.1
9.7
37
78
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
2.7
9.7
65
208
H3601, E113
ICD-10 Finland
NA
2.0
9.7
121
524
S22.4
ICD-10 Finland
Multiple fractures of ribs
1.9
9.7
130
581
E16.19
ICD-10 Finland
Other specified hypoglycaemia
4.7
9.6
32
59
SPAT1165
SPAT
Peritoneal dialysis
7.6
9.6
22
25
G41.0
ICD-10 Finland
Grand mal status epilepticus
7.1
9.6
23
28
N03AX15
ATC
zonisamide; oral
12.2
9.5
17
12
A10BA02
ATC
metformin; oral
1.2
9.5
2256
17167
K92.0
ICD-10 Finland
Haematemesis
1.8
9.5
150
710
TKC20
NOMESCO Finland
Catheterisation of bladder
1.4
9.5
534
3426
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
3.7
9.5
41
97
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
0.6
9.5
170
2325
J01FA10
ATC
azithromycin; systemic
0.9
9.5
2900
27501
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
3.2
9.4
48
129
I49.3
ICD-10 Finland
Ventricular premature depolarization
0.7
9.4
258
3243
PJA12
NOMESCO Finland
Sentinel node biopsy
0.7
9.4
273
3397
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
1.7
9.4
203
1058
SPAT1232
SPAT
Communication with help of interpreter or assistant
5.6
9.4
27
42
XX3DW
NOMESCO Finland
Time consuming IT work
0.7
9.4
492
5576
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.9
9.4
57
173
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.0
9.4
112
477
NF3AA
NOMESCO Finland
Femur X-ray examination
1.9
9.4
133
605
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
2.5
9.3
70
239
G04BD10
ATC
darifenacin; oral
2.7
9.3
64
209
F32.8
ICD-10 Finland
Other depressive episodes
2.7
9.3
61
194
R4130
NOMESCO Finland
Speech therapy
1.8
9.3
154
738
R45.5
ICD-10 Finland
Hostility
34.5
9.3
12
*
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
2.5
9.3
70
241
B01AC07
ATC
dipyridamole; systemic
1.5
9.3
285
1627
R1260
NOMESCO Finland
Evaluation of communicative skills
1.9
9.2
126
567
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
9.2
497
3168
A05
ICPC
Feeling ill
1.5
9.2
266
1497
RT250
NOMESCO Finland
NA
7.0
9.2
22
27
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.6
9.1
261
1464
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.7
9.1
185
949
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
1.9
9.1
137
637
N06AX05
ATC
trazodone; oral
1.9
9.1
127
575
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
1.9
9.1
135
626
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
9.7
9.1
18
16
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.4
9.1
50
953
F61.0
ICD-10 Finland
Mixed personality disorders
2.8
9.1
58
182
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
1.8
9.0
157
767
N05BA12
ATC
alprazolam; oral
1.3
9.0
604
3981
A99
ICPC
Disease/condition unspecnature/site
1.3
9.0
559
3646
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.6
9.0
39
93
Z20.8
ICD-10 Finland
Contact with and exposure to other communicable diseases
1.6
9.0
205
1087
S52.5
ICD-10 Finland
Fracture of lower end of radius
1.3
8.9
661
4421
F32.1
ICD-10 Finland
Moderate depressive episode
1.7
8.9
165
821
N07
ICPC
Convulsion/seizure
5.9
8.9
24
35
F000, G300
ICD-10 Finland
NA
+∞
8.8
9
*
F00.02
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions
+∞
8.8
9
*
F0204, G310
ICD-10 Finland
NA
+∞
8.8
9
*
F01.89
ICD-10 Finland
Other specified vascular dementia without information on additional symptoms
86.3
8.8
10
*
F01.22
ICD-10 Finland
Subcortical vascular dementia with additional symptoms, mainly hallucinations
86.3
8.8
10
*
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
4.1
8.8
33
69
U29
ICPC
Urinary symptom/complaint other
1.6
8.8
197
1039
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
1.9
8.8
121
547
L03AA13
ATC
pegfilgrastim; parenteral
0.6
8.8
99
1516
NG1AA
SPAT
NA
0.4
8.8
26
631
N06AA12
ATC
doxepin; systemic
1.4
8.8
360
2183
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
3.9
8.7
35
78
P18
ICPC
Medication abuse
5.2
8.7
26
43
X58
ICD-10 Finland
Exposure to other specified factors
1.3
8.7
726
4940
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.4
8.6
451
2857
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
2.5
8.6
67
236
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
8.6
2122
16170
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.3
8.6
694
4700
WX111
NOMESCO Finland
Local infiltration anesthesia
0.6
8.6
107
1597
C07AB02
ATC
metoprolol; systemic
1.2
8.6
1674
12500
OAA80
SPAT
NA
0.2
8.6
6
317
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
2.1
8.6
98
413
Z60.9
ICD-10 Finland
Problem related to social environment, unspecified
6.3
8.6
22
30
G40.10
ICD-10 Finland
Simple partial seizures
2.9
8.5
51
154
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.1
8.5
3468
27459
81
HP
Angiography of the heart and coronary arteries
1.3
8.5
521
3390
EB1AA
SPAT
NA
0.6
8.5
100
1512
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
1.6
8.5
192
1018
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
2.2
8.5
85
339
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.3
8.4
661
4458
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
5.3
8.4
25
41
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
0.7
8.4
445
5031
IGV01
NOMESCO Finland
Psychiatric network contact
5.0
8.4
26
45
P27
ICPC
Fear of mental disorder
3.0
8.4
46
132
N05AA01
ATC
chlorpromazine; systemic, rectal
2.4
8.3
70
255
R50.9
ICD-10 Finland
Fever, unspecified
1.3
8.3
863
6035
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.9
8.3
33
73
F22.8
ICD-10 Finland
Other persistent delusional disorders
6.5
8.3
21
28
J01MA02
ATC
ciprofloxacin; systemic
1.2
8.3
2895
22649
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.8
8.3
633
6836
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
2.0
8.3
106
464
A03FA02
ATC
cisapride; oral, rectal
1.3
8.3
539
3538
Z59.8
ICD-10 Finland
Other problems related to housing and economic circumstances
8.2
8.3
18
19
G23.8
ICD-10 Finland
Other specified degenerative diseases of basal ganglia
7.5
8.3
19
22
AAF00
NOMESCO Finland
Ventriculostomy
2.9
8.3
48
142
D09
ICPC
Nausea
1.6
8.2
186
984
G02CB01
ATC
bromocriptine; systemic
2.9
8.2
49
148
S32.5
ICD-10 Finland
Fracture of pubis
2.7
8.2
56
182
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
3.4
8.2
38
96
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
0.5
8.2
82
1294
F10.74
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol otherwise permanently impaired intelligence
16.0
8.2
13
7
S01BC05
ATC
ketorolac; ophthalmic
1.5
8.2
253
1448
N03AX12
ATC
gabapentin; oral
1.2
8.2
1045
7484
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
0.3
8.1
18
499
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
1.8
8.1
144
711
F02.84
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere as other mixed symptoms of mixed type
43.1
8.1
10
*
NB6AA
NOMESCO Finland
Humerus X-ray examination
1.8
8.1
136
659
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
5.5
8.1
23
36
SPAT1277
SPAT
Instruction concerning legal protection and patient’s rights
6.6
8.1
20
26
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.2
8.1
1743
13124
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
2.7
8.1
55
179
A10AA01
ATC
NA
1.9
8.0
109
492
P98
ICPC
Psychosis NOS/other
4.1
8.0
30
63
R39.1
ICD-10 Finland
Other difficulties with micturition
1.6
8.0
208
1144
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
3.6
8.0
35
85
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
1.9
8.0
118
549
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
6.0
7.9
21
30
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
3.1
7.9
41
113
G21.8
ICD-10 Finland
Other secondary parkinsonism
5.4
7.9
23
37
I67.4
ICD-10 Finland
Hypertensive encephalopathy
9.2
7.9
16
15
SPF30
NOMESCO Finland
Soling for prothesis
1.7
7.9
166
859
F01.13
ICD-10 Finland
The other additional symptoms of multi-infarct dementia, mainly depression
77.6
7.9
9
*
F01.14
ICD-10 Finland
Multi-infarct dementia's other mixed symptoms of mixed type
77.6
7.9
9
*
Z50.5
ICD-10 Finland
Speech therapy
2.2
7.9
76
299
F02.89*M30.0
ICD-10 Finland
Dementia in polyarteritis nodosa
+∞
7.9
8
*
F00.0
ICD-10 Finland
Dementia in Alzheimer disease with early onset
+∞
7.9
8
*
F0022, G308
ICD-10 Finland
NA
+∞
7.9
8
*
F0230, G20
ICD-10 Finland
NA
+∞
7.9
8
*
F0021, G301
ICD-10 Finland
NA
+∞
7.9
8
*
F02.29*G10
ICD-10 Finland
Dementia in Huntington's disease without information on additional symptoms
+∞
7.9
8
*
F02.3
ICD-10 Finland
Dementia in Parkinson disease
+∞
7.9
8
*
F0234, G20
ICD-10 Finland
NA
+∞
7.9
8
*
F0021, G308
ICD-10 Finland
NA
+∞
7.9
8
*
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
0.7
7.8
200
2548
A12BA01
ATC
potassium chloride; oral
1.5
7.8
297
1773
A10BH01
ATC
sitagliptin; oral
1.3
7.8
747
5172
R40.0
ICD-10 Finland
Somnolence
4.6
7.8
26
49
OAB95
SPAT
NA
0.2
7.8
9
349
N05CD02
ATC
nitrazepam; oral
1.9
7.8
114
527
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
1.9
7.8
102
454
N43
ICPC
Neurological, Other diagnostic procedure
3.1
7.8
41
115
K03.66
ICD-10 Finland
Tooth plaque
1.4
7.8
386
2430
U07
ICPC
Urine symptom/complaint other
1.4
7.7
432
2770
F30.9
ICD-10 Finland
Manic episode, unspecified
5.4
7.7
22
35
C09AA05
ATC
ramipril; oral
1.2
7.7
2088
16016
XF400
NOMESCO Finland
ECG with 12 standard connections
1.2
7.7
1213
8876
F30.1
ICD-10 Finland
Mania without psychotic symptoms
8.6
7.7
16
16
K28
ICPC
Limited function/disability (K)
1.7
7.6
165
862
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
5.7
7.6
21
32
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.7
7.6
158
819
N06AG02
ATC
moclobemide; oral
1.5
7.6
291
1746
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.0
7.5
43
125
JN4AD
NOMESCO Finland
Body CT examination
0.7
7.5
375
4279
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
4.1
7.5
28
59
N06BA04
ATC
methylphenidate; oral
3.5
7.5
34
85
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
9.2
7.5
15
14
J01.0
ICD-10 Finland
Acute maxillary sinusitis
0.8
7.5
782
8152
L03AA14
ATC
lipegfilgrastim; parenteral
0.4
7.4
28
612
G93.4
ICD-10 Finland
Encephalopathy, unspecified
4.7
7.4
24
44
S72.2
ICD-10 Finland
Subtrochanteric fracture
2.6
7.4
51
167
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.8
7.4
522
5688
U05
ICPC
Urination problems other
1.4
7.4
355
2218
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.7
7.4
151
780
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.6
7.3
51
169
N06AX18
ATC
reboxetine; oral
2.3
7.3
66
251
ZYC01
SPAT
NA
1.5
7.3
273
1629
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.4
7.3
407
2613
SPAT1313
SPAT
Guidance and counselling related to accident prevention
2.7
7.3
48
156
XKD00
NOMESCO Finland
Uroflowmetry
1.2
7.2
1424
10629
S32.8
ICD-10 Finland
Fracture of other and unspecified parts of lumbar spine and pelvis
2.3
7.2
65
246
G40.3
ICD-10 Finland
Generalized idiopathic epilepsy and epileptic syndromes
7.0
7.2
17
21
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
0.4
7.2
25
562
R54
ICD-10 Finland
Senility
4.7
7.2
23
42
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.5
7.2
39
742
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
0.7
7.1
265
3158
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
0.6
7.1
85
1281
SPAT1153
SPAT
Removal of sutures
0.9
7.1
2305
21895
GD1AA
SPAT
NA
0.6
7.1
80
1223
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.8
7.1
552
5944
N06AA04
ATC
clomipramine; systemic
1.9
7.1
103
479
N32.0
ICD-10 Finland
Bladder-neck obstruction
2.1
7.1
79
330
P19
ICPC
Drug abuse
3.8
7.1
28
63
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.3
7.1
463
3047
S42.0
ICD-10 Finland
Fracture of clavicle
1.7
7.0
142
730
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
21.6
7.0
10
*
ZXC96
NOMESCO Finland
Robot assisted procedure
0.6
7.0
77
1181
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
0.5
7.0
60
987
AA400
NOMESCO Finland
Electroconvulsive therapy
2.8
7.0
42
129
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.4
7.0
283
1715
AA1ED
NOMESCO Finland
Trauma CT of head and neck
3.1
7.0
36
100
N05AE03
ATC
sertindole; oral
8.1
7.0
15
16
G40.36
ICD-10 Finland
Juvenile myoclonic epilepsy [impulsive petit mal]
69.0
7.0
8
*
OAA65
SPAT
NA
0.4
6.9
26
571
R26
ICD-10 Finland
Abnormalities of gait and mobility
3.5
6.9
30
73
R01AD12
ATC
fluticasone furoate; nasal
0.8
6.9
1089
10925
F01.32
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly hallucinations
+∞
6.9
7
*
F0012, G301
ICD-10 Finland
NA
+∞
6.9
7
*
F00.03
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression
+∞
6.9
7
*
F01.81
ICD-10 Finland
Other specified vascular dementia has other additional symptoms, mainly paranoidism
+∞
6.9
7
*
F01.11
ICD-10 Finland
The other additional symptoms of multi-infarct dementia, mainly paranoidism
+∞
6.9
7
*
F02.89*T58
ICD-10 Finland
Dementia with carbon monoxide intoxication
+∞
6.9
7
*
F0013, G301
ICD-10 Finland
NA
+∞
6.9
7
*
Q90
ICD-10 Finland
Down syndrome
+∞
6.9
7
*
F0282, G318
ICD-10 Finland
NA
+∞
6.9
7
*
J01DB01
ATC
cefalexin; oral
1.1
6.9
6079
50360
ZX080
NOMESCO Finland
Image guided radiotherapy
0.5
6.8
47
829
G91.1
ICD-10 Finland
Obstructive hydrocephalus
3.7
6.8
28
65
RS230
NOMESCO Finland
NA
3.3
6.8
32
83
A02BC01
ATC
omeprazole; systemic
1.2
6.8
1971
15171
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
1.4
6.8
285
1741
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
3.8
6.8
27
61
K80
ICPC
Cardiac arrhythmia NOS
0.7
6.8
348
3951
G72.9
ICD-10 Finland
Myopathy, unspecified
2.4
6.8
55
200
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
1.9
6.8
92
417
TNC33
NOMESCO Finland
Custom moulded brace, elbow or forearm
4.4
6.8
23
45
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
4.2
6.8
24
49
F10.8
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Other mental and behavioural disorders
7.6
6.7
15
17
N30
ICD-10 Finland
Cystitis
1.3
6.7
405
2631
L02BB04
ATC
enzalutamide; oral
0.3
6.7
12
367
G21.0
ICD-10 Finland
Malignant neuroleptic syndrome
11.5
6.7
12
9
C07AA05
ATC
propranolol; systemic
1.2
6.7
1025
7470
R4120
NOMESCO Finland
Occupational therapy
1.4
6.7
377
2425
A10BH05
ATC
linagliptin; oral
1.4
6.7
382
2462
I95.2
ICD-10 Finland
Hypotension due to drugs
2.4
6.7
56
205
DJA10
NOMESCO Finland
Biopsy of septum of nose
5.8
6.7
18
27
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
1.7
6.7
134
691
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
0.7
6.7
199
2455
A02BA02
ATC
ranitidine; systemic
1.2
6.6
1397
10480
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
3.4
6.6
30
76
F06.4
ICD-10 Finland
Organic anxiety disorder
13.6
6.6
11
7
T68
ICD-10 Finland
Hypothermia
3.2
6.6
33
90
Z00.0
ICD-10 Finland
General medical examination
1.2
6.6
1265
9414
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
0.5
6.6
49
843
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
9.3
6.6
13
12
Y96.9
ICD-10 Finland
Unspecified type of accident
1.9
6.6
95
442
163
Kela drug reimbursment
Abiraterone and enzalutamide
0.3
6.6
18
450
D11
ICPC
Diarrhoea
1.3
6.6
519
3509
SPAT1111
SPAT
Planning of analgesia
2.0
6.6
74
314
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
1.6
6.6
181
1011
8113
FHL
Fractional scraping
1.3
6.5
531
3601
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
3.2
6.5
32
86
T90
ICPC
Diabetes non-insulin dependent
1.2
6.5
1905
14663
A78
ICPC
Infectious disease other/NOS
2.1
6.5
66
266
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
3.6
6.5
28
68
SPAT1042
SPAT
Guidance concerning balance maintenance
2.6
6.5
46
155
SPAT1241
SPAT
Extensive assessment of psychosocial situation
2.7
6.5
42
134
T89
ICPC
Diabetes insulin dependent
1.6
6.5
165
904
S22
ICPC
Nail symptom/complaint
1.3
6.5
405
2646
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
5.5
6.5
18
28
WF003
NOMESCO Finland
Adjuvant radiotherapy
0.6
6.5
121
1636
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.2
6.5
993
7238
115
Kela drug reimbursment
Breast cancer
0.7
6.5
320
3649
R4150
NOMESCO Finland
Neuropsychological rehabilitation
3.2
6.5
32
87
S12
ICPC
Insect bite/sting
0.8
6.5
385
4281
N06AA06
ATC
trimipramine; systemic
1.6
6.5
145
770
T93
ICPC
Lipid disorder
0.7
6.4
250
2955
JN4BD
NOMESCO Finland
Extensive body CT
0.8
6.4
632
6633
PA7BD
NOMESCO Finland
CT angiography of neck and brain
1.7
6.4
131
678
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
4.8
6.4
20
36
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
4.8
6.4
20
36
Z93.5
ICD-10 Finland
Cystostomy status
4.0
6.4
24
52
D19
ICPC
Teeth/gum symptom/complaint
0.8
6.4
1093
10894
S01.3
ICD-10 Finland
Open wound of ear
2.1
6.4
67
274
F10.4
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium
4.5
6.4
21
40
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.4
6.4
336
2141
G81.9
ICD-10 Finland
Hemiplegia, unspecified
2.2
6.3
58
225
F41.8
ICD-10 Finland
Other specified anxiety disorders
2.2
6.3
62
246
N06AX22
ATC
agomelatine; oral
2.2
6.3
62
246
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
2.5
6.3
46
159
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
2.4
6.3
49
175
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.1
6.3
2843
22527
Z74.0
ICD-10 Finland
Need for assistance due to reduced mobility
7.5
6.3
14
16
F45.0
ICD-10 Finland
Somatization disorder
3.2
6.3
31
84
F41.09
ICD-10 Finland
UNS Panic Syndrome
1.9
6.3
82
366
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
0.1
6.3
*
188
P20
ICD-10 Finland
Intrauterine hypoxia
11.9
6.3
11
8
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
5.0
6.3
19
33
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.3
6.3
366
2367
SPAT1062
SPAT
Lung clearance therapy
3.9
6.3
24
53
WYA30
SPAT
NA
2.8
6.3
37
113
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
5.6
6.3
17
26
K88
ICPC
Postural hypotension
2.1
6.2
66
271
P16
ICPC
Acute alcohol abuse
2.1
6.2
64
261
B01AB10
ATC
tinzaparin; parenteral
0.7
6.2
306
3493
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.0
6.2
77
337
SPAT1109
SPAT
Analgesia with portable analgesic pump
2.5
6.2
47
164
F80.1
ICD-10 Finland
Expressive language disorder
2.6
6.2
42
140
RS121
NOMESCO Finland
NA
2.7
6.2
40
128
T91.8
ICD-10 Finland
Sequelae of other specified injuries of neck and trunk
6.0
6.2
16
23
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
1.6
6.2
144
775
H53.4
ICD-10 Finland
Visual field defects
1.6
6.2
134
707
T33.5
ICD-10 Finland
Superficial frostbite of wrist and hand
19.4
6.2
9
*
S02.30
ICD-10 Finland
Fracture of orbital floor, closed
2.4
6.2
50
182
G41.1
ICD-10 Finland
Petit mal status epilepticus
9.4
6.1
12
11
A10BB07
ATC
glipizide; oral
1.9
6.1
79
354
H47.2
ICD-10 Finland
Optic atrophy
3.0
6.1
32
91
JDB10
NOMESCO Finland
Percutaneous gastrostomy
1.9
6.1
85
392
A69.2
ICD-10 Finland
Lyme disease
0.7
6.1
180
2222
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
3.4
6.1
27
68
4019X
ICD-9 Finland
Essential hypertension, Unspecified
1.5
6.1
195
1130
M05BA04
ATC
alendronic acid; oral
1.3
6.0
625
4371
J01FA09
ATC
clarithromycin; systemic
0.9
6.0
1460
14175
G31
ICD-10 Finland
Other degenerative diseases of nervous system, not elsewhere classified
60.4
6.0
7
*
R21
ICPC
Throat symptom/complaint
0.8
6.0
598
6270
A01AB09
ATC
miconazole; local oral
1.3
6.0
570
3944
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
905
1444
4.49
315.03
1.2
1.4
e6/l
12.1
25.5
1.10
723
1129
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
904
1444
4.49
314.26
1.3
1.4
e6/l
484.6
2518.7
0.77
745
1192
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
913
1488
4.40
309.79
1.2
1.2
mmol/l
3.9
3.8
0.61
853
1401
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
1036
1714
4.36
307.65
1.2
1.3
mg/l
505.6
586.5
1.68
944
1640
(3009466) Valproate [Moles/volume] in Serum or Plasma
707
845
5.96
307.65
4.0
3.9
umol/l
335.7
342.1
0.43
574
707
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
895
376
17.20
307.65
1.0
1.0
ng/l
383.0
282.1
8.78
652
236
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
907
371
17.68
307.65
1.0
1.0
ng/l
578.7
775.4
12.36
639
224
(3019309) Folate [Moles/volume] in Red Blood Cells
7735
24496
3.00
307.65
2.0
1.8
nmol/l
1181.2
1142.7
2.77
5795
17840
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
5933
24871
1.94
307.65
1.8
1.7
pmol/l
3827185.0
31926209.0
8.77
4756
19561
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
908
374
17.56
307.65
1.0
1.0
ng/l
52.5
36.9
9.77
651
227
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
9793
49660
1.75
284.92
2.4
2.1
pmol/l
91.3
93.4
4.11
5274
25317
(3021960) Folate [Moles/volume] in Serum or Plasma
6526
29696
1.79
271.93
1.7
1.6
nmol/l
20.0
20.4
1.16
5608
24767
(3044290) Cell count panel - Cerebral spinal fluid
801
1376
4.15
254.07
1.2
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
5055
22288
1.77
225.36
2.8
3.2
mmol/l
2.5
2.5
12.78
4349
19234
(3015377) Calcium [Moles/volume] in Serum or Plasma
7676
38137
1.66
220.12
2.5
3.4
mmol/l
2.3
2.4
1.10
6370
32060
(3026008) Bacteria identified in Urine by Culture
7613
38180
1.63
206.31
4.0
3.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
6829
34712
1.56
163.59
4.1
4.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
415
605
4.82
159.53
1.3
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
4333
42384
0.62
154.15
2.1
2.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
4466
20825
1.63
151.29
1.9
1.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
10488
59121
1.51
150.94
5.4
6.7
mmol/l
1.2
1.2
25.32
8519
49293
(3024561) Albumin [Mass/volume] in Serum or Plasma
9152
50250
1.50
148.55
3.7
4.7
g/l
34.4
34.3
0.41
8137
46118
(3031040) Bacteria [#/volume] in Urine by Automated count
12330
72089
1.52
147.29
6.4
5.2
e6/l
3001.3
1217.8
2.47
319
1104
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2333
26455
0.55
146.56
1.5
1.6
mmol/l
1.2
1.3
1.46
1919
21489
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1869
7024
1.93
131.25
1.6
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
8287
45605
1.45
124.42
4.8
4.3
ng/l
83.4
80.8
0.04
6742
36068
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
9496
53677
1.45
123.25
4.9
6.0
mmol/l
1.2
1.2
10.94
8339
47872
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
7674
41936
1.44
117.16
2.2
2.2
nmol/l
77.5
81.0
18.56
6445
36048
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
6613
35219
1.46
115.09
2.4
2.1
u/l
259.6
211.4
3.89
6146
32631
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
3063
14296
1.57
97.47
1.8
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
3058
14396
1.56
93.28
1.8
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
357
733
3.41
88.14
1.2
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
11991
92058
0.72
87.97
4.2
4.9
mmol/l
1.4
1.4
0.98
10325
81546
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
12222
93036
0.73
78.03
4.2
4.9
mmol/l
4.3
4.4
19.87
10593
83165
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
11627
89001
0.74
75.07
3.8
4.4
mmol/l
1.2
1.3
4.43
9889
77947
(3012516) Albumin [Mass/volume] in Urine
4142
36733
0.72
71.63
2.9
3.3
mg/l
519.6
380.5
0.97
2658
23241
(3019150) Specific gravity of Urine by Refractometry
4228
22229
1.40
71.22
5.5
4.7
kg/l
1.0
1.0
1.03
721
3651
(3018418) pH of Serum or Plasma
6276
35182
1.35
70.93
3.2
4.2
ph
7.4
7.4
1.23
1108
6688
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1237
13987
0.58
69.58
1.2
1.2
u/ml
13.8
16.5
0.50
361
4561
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
5645
31370
1.35
66.51
2.3
2.3
mg/l
3.1
3.1
0.17
4568
26491
(3009508) Creatinine [Moles/volume] in Urine
4215
36941
0.73
66.32
2.8
3.2
mmol/l
7.0
6.9
1.18
3299
30050
(4035726)
836
10384
0.54
65.77
1.3
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1374
14932
0.61
65.55
1.2
1.3
iu/ml
47.4
42.0
0.51
414
4533
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
12785
95919
0.75
64.35
4.8
5.6
mmol/l
2.4
2.5
27.69
11092
85448
(3020682) Albumin/Creatinine [Ratio] in Urine
4500
38860
0.74
63.52
3.5
4.0
mg/mmol
12.0
9.7
1.50
2817
24269
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
965
3716
1.84
61.34
1.2
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
263
594
3.09
56.02
2.4
2.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
2645
24428
0.71
55.31
3.4
3.5
—
—
—
0
0
(3002256) Pathology report gross observation
1425
14825
0.64
55.30
1.3
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
353
960
2.57
53.71
1.3
1.2
nmol/l
313.4
310.5
0.08
277
713
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
6517
37839
1.29
52.80
5.5
4.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
7127
41996
1.28
50.74
2.5
2.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
746
8919
0.56
50.64
1.3
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
316
840
2.62
50.32
3.3
3.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
11669
73056
1.27
49.55
5.4
4.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
10545
65425
1.26
47.04
4.8
4.8
mmol/l
7.1
6.9
13.83
9953
61552
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1715
8204
1.49
46.03
1.8
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
4906
27840
1.29
45.88
5.4
4.6
estimate
0.0
0.0
1.73
1322
9073
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
12210
90792
0.80
43.22
19.4
17.7
ml/min/173m2
69.2
70.0
4.26
9969
75646
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1823
8993
1.44
41.57
1.6
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
777
8740
0.60
41.41
1.5
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1304
6035
1.53
40.79
1.8
1.6
%
1.7
1.6
0.67
1059
4890
(3003694) ABO and Rh group [Type] in Blood
2751
24251
0.75
40.58
1.2
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1134
11560
0.66
38.89
1.2
1.3
titre
523.5
528.4
0.03
243
2689
(3035350) Ketones [Presence] in Urine by Test strip
8260
50508
1.23
38.61
4.9
4.1
estimate
0.0
0.0
0.50
1454
9539
(3023183) Ammonium ion [Moles/volume] in Plasma
554
2080
1.86
38.03
1.9
2.1
umol/l
28.0
34.0
6.39
422
1683
(3000492) Spirometry study
668
7603
0.59
37.17
1.4
1.6
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
151
313
3.35
36.99
1.2
1.2
%
41.7
57.4
—
6
42
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
148
2803
0.36
35.56
1.5
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
821
8802
0.63
35.46
1.3
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
3382
18834
1.29
35.00
30.0
31.7
inr
1.6
1.5
1.07
380
2550
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
11319
71861
1.22
34.83
3.8
4.0
pmol/l
15.2
15.2
1.54
9812
63118
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
270
799
2.35
34.54
1.3
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
8302
51223
1.21
33.71
5.0
4.2
estimate
0.0
0.0
1.34
1426
9428
(3026493) Urate [Moles/volume] in Serum or Plasma
3495
29077
0.79
31.45
2.5
3.0
umol/l
8524.6
6657.8
1.11
2753
24302
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
219
616
2.47
31.30
1.2
1.2
mmol/l
2.0
2.3
2.50
201
563
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
2210
11779
1.33
31.08
2.5
2.5
ug/l
5.2
6.6
3.91
1611
10120
(3021589) Normoblasts [#/volume] in Blood
5660
44662
0.82
30.67
10.7
10.7
e9/l
0.0
0.0
0.87
4655
36243
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
925
4224
1.54
30.61
2.0
2.2
ug/l
838.3
539.6
0.65
856
4001
(3022145) Colonoscopy Study observation
1211
11678
0.70
30.53
1.3
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
70
1799
0.27
30.50
1.4
1.5
—
—
—
0
0
(4010399)
757
7996
0.64
30.40
1.4
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
8159
50588
1.20
30.16
6.5
5.6
estimate
0.0
0.0
0.80
1430
9586
(3024354) Oxygen [Partial pressure] in Venous blood
1887
9902
1.35
29.35
3.0
3.1
kpa
4.2
4.4
4.33
1810
9551
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
133
301
3.06
28.48
3.1
2.6
umol/l
29.1
29.3
0.07
97
227
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
1120
5416
1.45
28.03
2.0
1.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
202
578
2.43
27.90
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
1047
5013
1.47
27.57
1.9
1.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1582
14378
0.74
27.49
2.7
3.9
ug/l
18.0
25.1
0.68
1299
12017
(40761535) Cells panel - Urine sediment
1874
9928
1.34
27.26
3.8
3.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
64
1600
0.27
26.61
1.2
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1675
14989
0.75
26.04
1.2
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
13457
87930
1.20
24.98
5.0
5.0
mu/l
2.0
2.1
2.50
11881
77727
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1541
8028
1.35
24.96
5.2
6.6
mmol/l
24.6
24.6
0.15
1460
7467
(3013139) Helicobacter pylori Ag [Presence] in Stool
612
6484
0.64
24.81
1.2
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
74
124
4.13
24.43
11.5
11.4
nmol/l
618.1
835.9
3.56
69
115
(3026782) Osmolality of Urine
4127
24363
1.22
24.29
3.2
2.9
mosm/kgh2o
559.5
543.7
5.19
3513
20590
(3019832) Treponema pallidum Ab [Presence] in Serum
519
2192
1.65
23.83
1.2
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
6536
50090
0.85
23.26
4.0
4.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
1196
6059
1.39
23.02
4.0
4.3
%
46.0
46.3
0.17
1184
5980
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
129
339
2.64
21.30
2.7
2.0
umol/l
64.7
55.9
1.85
87
255
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
14605
96595
1.19
20.91
20.9
18.1
mg/l
30.0
27.4
14.08
12667
79697
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
12653
91710
0.85
20.31
6.7
6.9
mmol/mol
42.3
41.1
29.71
11086
82445
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
13144
94942
0.85
19.91
4.9
5.4
mmol/l
6.2
6.1
9.23
11299
83647
(4094501)
190
2578
0.50
19.53
1.1
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
618
2852
1.51
19.52
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
618
2852
1.51
19.52
1.4
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
400
4414
0.62
19.43
2.8
4.0
u/ml
125.4
88.3
0.45
378
4224
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
81
172
3.26
19.35
17.1
10.7
mmol/l
0.7
0.6
0.91
73
154
(3002179) Metamyelocytes/100 leukocytes in Blood
922
8641
0.72
19.23
3.1
3.7
%
0.8
0.6
0.44
198
2126
(3012544) pH of Venous blood
2210
12517
1.25
18.77
3.2
3.7
ph
7.4
7.4
—
9
69
(3021447) Carbon dioxide [Partial pressure] in Venous blood
2142
12090
1.25
18.76
3.2
3.7
kpa
5.8
5.8
0.05
2065
11722
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
2522
14514
1.23
18.47
10.2
8.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
5550
34302
1.17
18.33
2.4
2.5
u/l
57.2
60.4
3.61
5053
31320
(3002032) Base excess in Venous blood by calculation
2133
12069
1.25
18.25
3.2
3.7
mmol/l
2.1
1.9
1.33
1749
9738
(3000850) Epithelial cells [#/volume] in Urine
4252
25744
1.18
18.09
3.0
2.7
e6/l
5.5
4.9
2.57
3738
22449
(3041096) Erythrocytes [Presence] in Urine by Automated
4209
25486
1.18
17.84
4.8
4.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1872
15804
0.80
17.78
1.4
1.5
g/l
2.9
2.7
1.48
952
8551
(3002582) Erythrocytes [#/volume] in Urine
5844
36371
1.16
17.38
3.8
3.5
e6/l
106.1
116.9
0.18
4637
28280
(3017181) Myelocytes/100 leukocytes in Blood
1058
9568
0.75
17.34
3.2
3.8
%
1.0
0.9
0.21
300
2974
(4027681)
101
261
2.68
17.31
1.3
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
247
2988
0.56
17.31
1.2
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
98
251
2.70
17.09
1.3
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
1000
9086
0.75
16.93
3.2
3.8
%
0.1
0.1
0.08
275
2778
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
3046
24386
0.84
16.88
3.0
3.5
ug/l
0.8
0.8
0.44
2183
18147
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
144
446
2.24
16.88
1.3
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
759
3758
1.41
16.70
3.3
4.1
mmol/l
3.9
3.9
0.18
683
3524
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
88
216
2.82
16.60
1.3
1.2
%
49.6
26.5
—
5
35
(3019225) pH of Specimen
2201
12632
1.23
16.42
4.1
4.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
1232
6595
1.31
16.42
3.3
3.5
mmol/l
25.3
25.1
1.16
1200
6410
(3025159) Blasts/100 leukocytes in Blood
921
8432
0.74
16.42
3.2
3.8
%
0.5
0.3
0.18
227
2341
(3028707) Methadone [Presence] in Urine by Screen method
84
203
2.86
16.30
2.1
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
1129
5980
1.32
16.23
2.6
2.6
%
1.1
1.1
0.11
1123
5946
(3020191) Ethanol [Moles/volume] in Serum or Plasma
151
488
2.14
16.00
1.4
1.2
promille
1.0
1.0
0.20
121
368
(3018095) Leukocytes [#/volume] in Urine
6500
40940
1.15
16.00
4.3
4.0
e6/l
160.1
124.6
1.19
4861
29988
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
1107
5873
1.32
15.74
2.6
2.6
%
0.7
0.7
3.00
1059
5638
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
131
407
2.23
15.29
1.1
1.1
mg/l
33.5
45.7
4.39
105
355
(3018405) Lactate [Moles/volume] in Arterial blood
864
4445
1.36
15.11
3.2
3.8
mmol/l
1.4
1.4
0.57
848
4356
(3040151) Glucose [Moles/volume] in Capillary blood
349
1501
1.62
15.08
7.4
8.1
mmol/l
7.9
7.3
1.81
269
1241
(3005322) IgE [Units/volume] in Serum or Plasma
433
4442
0.67
15.02
1.3
1.3
u/ml
234.5
252.8
0.22
386
4026
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
475
4785
0.68
15.00
1.9
3.1
u/ml
285.2
2432.5
2.80
379
4087
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
205
2502
0.56
14.89
1.2
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
4084
25003
1.16
14.62
4.7
4.0
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
123
380
2.24
14.58
1.1
1.1
mg/l
251.6
326.1
4.40
102
340
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
136
440
2.14
14.42
1.1
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
207
2497
0.57
14.42
2.3
2.2
%
206.5
209.6
0.20
188
2364
(40768443) Skin Pathology biopsy report
537
5242
0.70
14.28
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
171
2158
0.54
14.00
1.2
1.3
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
59
127
3.21
13.92
1.1
1.2
%
25.8
52.3
2.61
18
59
(3033705) Calcium.ionized [Moles/volume] in Venous blood
419
1917
1.52
13.90
2.7
2.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
46
962
0.33
13.88
1.3
1.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
1031
5512
1.31
13.87
3.9
4.8
%
1.6
1.6
0.38
984
5181
(3022621) pH of Urine by Test strip
1339
7409
1.27
13.78
4.1
3.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
8080
59626
0.89
13.62
6.6
8.7
e9/l
4.7
4.4
20.87
6970
51338
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
62
140
3.06
13.57
2.3
2.2
nmol/l
140.1
128.8
0.40
49
120
(3004119) Hemoglobin [Mass/volume] in Venous blood
1404
7831
1.26
13.50
3.2
3.3
g/l
127.0
126.2
0.73
1375
7627
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
285
3120
0.62
13.46
1.5
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
1559
8802
1.24
13.46
3.6
4.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
109
1559
0.48
13.27
1.2
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
231
2646
0.60
13.22
2.0
2.0
%
93.0
87.5
3.40
211
2500
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
854
7655
0.76
13.07
1.4
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
129
428
2.09
12.89
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
991
8694
0.77
12.86
3.0
2.9
ml/min/173m2
59.3
57.3
1.01
417
3907
(3007930) Methemoglobin/Hemoglobin.total in Blood
1011
5454
1.30
12.73
3.9
4.8
%
0.9
0.9
1.83
969
5117
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
253
2806
0.62
12.67
1.8
3.0
u/ml
199.6
782.9
3.03
215
2552
(4034850)
625
3148
1.38
12.52
13.6
12.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
259
2846
0.62
12.47
2.6
2.1
g/l
3.6
3.7
0.48
242
2694
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1773
10250
1.21
12.17
3.4
3.9
mmol/l
1.2
1.2
0.50
1456
8872
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
145
1840
0.54
12.17
2.4
4.0
iu/ml
573.6
2002.4
0.85
14
278
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
33
52
4.39
11.89
2.5
2.0
umol/l
22.7
16.7
1.47
33
52
(3024891) Influenza virus A+B Ag [Presence] in Specimen
462
2229
1.44
11.84
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
189
2212
0.59
11.83
1.2
1.2
u/ml
10.1
5.2
0.34
29
381
(3045142) Bone marrow Pathology biopsy report
102
1432
0.49
11.82
1.2
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
188
2187
0.59
11.50
1.2
1.2
u/ml
14.8
4.6
0.40
19
248
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
241
2640
0.63
11.48
1.2
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
487
4646
0.72
11.36
1.3
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
723
3793
1.33
11.18
4.3
5.8
mmol/l
1.4
1.3
0.98
657
3366
(3022096) Basophils/100 leukocytes in Blood
6329
47024
0.89
11.16
5.0
5.9
%
0.6
0.6
7.78
5711
43251
(3028026) IgM [Mass/volume] in Serum or Plasma
613
5625
0.74
11.11
1.7
1.9
g/l
1.6
1.4
0.54
520
4994
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
208
2335
0.61
11.03
1.2
1.2
u/ml
30.3
40.0
0.20
15
133
(3032080) INR in Blood by Coagulation assay
7909
51211
1.11
11.00
11.2
11.5
inr
1.3
1.4
1.71
2058
13813
(3006504) Eosinophils/100 leukocytes in Blood
6512
48280
0.89
11.00
5.1
5.8
%
2.8
2.8
1.50
5869
44357
(4281824)
75
1141
0.45
10.94
1.1
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
6549
48529
0.89
10.93
5.4
6.2
%
8.8
9.0
3.30
5925
44702
(40768795) Lymph node Pathology biopsy report
69
1081
0.44
10.89
1.1
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
548
5095
0.73
10.86
1.3
1.5
u/ml
40.8
18.0
—
9
115
(3008898) HLA-B27 [Presence]
121
1561
0.53
10.79
1.0
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
415
4022
0.71
10.66
1.5
1.7
u/l
35.9
38.3
1.53
335
3378
(3038515) Glucose [Moles/volume] in Venous blood
606
3126
1.35
10.52
4.0
3.6
mmol/l
8.1
7.7
2.53
594
3060
(3001604) Monocytes [#/volume] in Blood
6907
50957
0.90
10.48
4.7
5.5
e9/l
0.6
0.6
0.20
5854
42879
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
137
1689
0.56
10.46
1.5
1.4
pmol/l
345.7
235.0
0.38
131
1634
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
332
3337
0.68
10.46
1.6
1.4
iu/ml
25.9
16.7
—
8
80
(3018010) Neutrophils/100 leukocytes in Blood
6545
48411
0.90
10.39
5.2
5.8
%
60.7
59.1
19.68
5899
44509
(3000494) Fungus identified in Specimen by Culture
1434
11805
0.83
10.37
1.3
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
500
2508
1.39
10.34
4.1
3.8
mg/l
31.3
29.6
0.42
362
1614
(3006315) Basophils [#/volume] in Blood
6963
51320
0.90
10.32
4.8
5.5
e9/l
0.0
0.0
2.93
5915
43227
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
109
372
2.03
10.22
1.1
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
3577
27377
0.88
10.16
2.3
2.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
628
3277
1.33
10.11
3.9
3.5
mmol/l
1.7
1.6
0.93
615
3204
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
161
1882
0.59
10.10
1.2
1.2
u/ml
1.9
6.2
1.59
15
154
(3015171) Extractable nuclear Ab [Units/volume] in Serum
326
3264
0.68
10.08
1.2
1.2
u/ml
0.4
0.9
1.50
36
329
(3044889) 12 lead EKG panel
9963
72036
0.90
10.01
4.7
4.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
7173
52723
0.90
9.96
4.9
5.7
e9/l
0.2
0.2
0.54
6120
45086
(3002030) Lymphocytes/100 leukocytes in Blood
6672
49219
0.90
9.92
5.3
6.0
%
24.0
25.5
18.85
5968
45027
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
58
152
2.64
9.88
2.2
2.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
151
1779
0.58
9.78
1.1
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
12246
81405
1.11
9.72
5.9
7.9
u/l
81.4
81.9
0.30
11156
76134
(36304419) Bacteria [Presence] in Urine
5009
31788
1.12
9.71
3.7
3.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
718
6315
0.78
9.53
2.0
2.0
nmol/l
10.9
11.0
0.00
588
5288
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
111
1410
0.54
9.46
1.7
2.1
u/ml
835.1
1859.9
—
9
102
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
57
152
2.59
9.41
2.2
2.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
70
207
2.34
9.34
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
73
221
2.28
9.24
1.1
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
244
2539
0.66
9.24
1.6
1.8
mg/l
12.6
12.1
0.42
213
2299
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
97
330
2.03
9.22
1.5
1.8
umol/l
105.6
103.9
0.03
54
191
(3017143) Hepatitis C virus Ab [Presence] in Serum
842
7216
0.80
8.99
1.4
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
414
3895
0.73
8.92
1.6
1.6
titre
160.8
248.1
0.71
24
187
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1977
15622
0.86
8.77
2.8
3.9
u/l
247.5
249.4
0.21
1757
14680
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
483
4428
0.75
8.76
1.1
1.2
iu/ml
92.2
129.1
1.39
160
1434
(3039000) Anion gap in Blood
530
2761
1.33
8.69
4.6
6.5
mmol/l
11.3
11.3
0.12
490
2471
(3018572) Chloride [Moles/volume] in Blood
530
2762
1.33
8.67
4.6
6.5
mmol/l
105.2
104.8
0.87
490
2472
(3027945) Reticulocytes/100 erythrocytes in Blood
2606
15982
1.15
8.64
2.0
2.3
%
1.7
1.8
0.55
2114
14003
(3005719) IgG [Mass/volume] in Serum or Plasma
826
7060
0.80
8.61
2.5
2.8
g/l
10.7
10.7
0.11
714
6424
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
994
5615
1.23
8.57
1.8
1.9
ug/l
3.1
2.2
0.83
774
4901
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
272
2726
0.68
8.52
1.8
1.5
g/l
1.1
1.2
0.27
255
2559
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
72
225
2.21
8.51
1.1
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1435
8413
1.19
8.46
1.7
2.2
nmol/l
395.6
381.8
1.12
1235
7628
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
334
3222
0.71
8.43
1.7
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
42
101
2.87
8.41
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
893
5003
1.24
8.31
4.1
4.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
171
1871
0.63
8.24
1.5
1.8
ug/l
17.4
24.5
3.18
164
1819
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
271
2698
0.69
8.21
2.1
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
51
799
0.44
8.18
1.2
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
7122
52027
0.91
8.11
4.9
5.6
e9/l
1.8
1.9
2.33
6086
44608
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
156
1735
0.62
8.08
1.5
1.6
mg/l
3.3
3.4
0.04
120
1277
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
71
226
2.17
8.05
1.1
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
267
2649
0.69
7.95
1.8
1.5
g/l
0.2
0.2
0.11
249
2475
(40760892) CBC W Ordered Manual Differential panel - Blood
2547
19642
0.88
7.92
4.0
4.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
62
188
2.28
7.89
1.5
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
86
1112
0.53
7.87
1.5
1.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
1146
6626
1.21
7.87
3.2
2.9
e6/l
0.4
0.3
0.86
1126
6511
(1761482) Bacteria [#/volume] in Urine by Culture
702
3855
1.27
7.79
5.6
4.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
39
665
0.40
7.76
1.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
89
315
1.95
7.67
2.0
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
3831
24231
1.11
7.59
4.4
4.2
ng/l
206.7
450.0
5.81
3387
21247
(42870588) Differential panel, method unspecified - Blood
4994
37002
0.91
7.52
4.6
5.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
79
270
2.02
7.51
2.5
1.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
231
2326
0.68
7.48
1.4
1.5
—
—
—
0
0
(4198724)
33
75
3.04
7.31
1.7
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
664
3655
1.26
7.26
3.7
3.1
nmol/l
0.8
0.8
0.17
503
2849
(3048689) Calprotectin [Mass/mass] in Stool
1174
9522
0.84
7.18
1.7
2.0
ug/g
188.2
163.1
1.10
854
7206
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
69
228
2.09
7.18
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
2407
14860
1.14
7.16
4.5
6.2
mmol/l
1.4
1.1
2.88
1812
11629
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
31
562
0.38
7.15
1.8
1.3
u/ml
1.2
1.4
0.08
24
313
(21494434) Karyotype in Bone marrow
102
1216
0.58
7.05
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
561
4892
0.79
7.02
2.5
2.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
5208
33573
1.10
7.01
3.7
3.4
e6/l
0.6
0.5
1.14
4126
25670
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
112
1300
0.59
6.99
1.2
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
147
1599
0.63
6.98
2.6
3.5
u/ml
29.8
45.0
1.59
138
1550
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
2029
12407
1.14
6.97
4.8
3.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1836
14350
0.87
6.94
4.3
5.1
%
34.6
33.7
2.58
1116
9165
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
19
30
4.37
6.90
1.6
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
145
1577
0.63
6.89
1.1
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
126
1409
0.61
6.77
1.2
1.3
nmol/l
0.2
0.3
0.27
11
106
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
191
871
1.52
6.70
1.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
194
889
1.51
6.65
1.3
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
126
1400
0.62
6.60
1.2
1.3
nmol/l
0.6
1.6
0.65
113
1332
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
94
1123
0.58
6.59
1.0
1.1
g/l
1.6
1.6
0.44
83
990
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
47
137
2.37
6.59
1.1
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
74
260
1.97
6.58
1.7
1.2
nmol/l
99.0
133.0
1.29
55
191
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
80
996
0.55
6.52
1.1
1.1
—
—
—
0
0
(3036603) Volume of Urine
57
786
0.50
6.49
1.4
1.6
ml
1697.8
1872.5
0.44
25
222
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
509
2752
1.28
6.48
1.2
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
3693
27597
0.91
6.45
3.6
4.0
%
80.9
83.2
6.00
3564
26982
(1002224) Polysomnography panel
176
1808
0.67
6.40
1.0
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
2096
12924
1.13
6.34
1.8
1.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
208
2066
0.69
6.33
2.3
2.7
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
390
2041
1.33
6.32
1.9
1.9
mmol/l
1.9
1.7
2.30
382
1998
(42529406) Shigella sp [Presence] in Stool by Culture
514
2793
1.28
6.30
1.2
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1317
7863
1.17
6.28
3.3
3.7
mmol/l
2.1
2.0
0.25
956
5867
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
142
1518
0.64
6.28
1.2
1.2
u/ml
34.8
46.1
0.30
12
157
(3023419) Bacteria identified in Sputum by Culture
160
1668
0.66
6.27
1.8
2.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
512
2783
1.28
6.26
1.2
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
449
2404
1.30
6.18
1.4
1.3
mmol/l
65.1
61.2
1.37
362
1944
(3025941) Bacteria identified in Stool by Culture
858
4943
1.21
6.18
1.3
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
2150
13308
1.13
6.11
4.6
6.5
%
95.0
95.3
1.24
2059
12776
(3009343) pH of Capillary blood
1357
8143
1.16
6.07
3.3
3.8
ph
7.4
7.4
0.45
170
1085
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
137
1464
0.64
6.06
1.5
1.6
nmol/l
53.4
48.4
1.18
127
1376
(3001122) Ferritin [Mass/volume] in Serum or Plasma
6288
41081
1.08
6.04
2.7
2.9
ug/l
145.5
161.1
4.84
5401
36817
(3036489) Thrombin time
398
3548
0.77
6.00
1.8
1.8
s
21.2
22.1
1.38
358
3205
(3024980) IgG subclass 4 [Mass/volume] in Serum
124
1351
0.63
6.00
1.4
1.6
g/l
0.7
0.9
0.64
95
1004
(3027801) Oxygen [Partial pressure] in Arterial blood
2387
14889
1.12
5.97
4.5
6.2
kpa
11.3
11.8
4.58
2245
14098
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
2388
14901
1.12
5.93
4.5
6.2
kpa
5.0
5.1
3.13
2251
14112
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
384
3428
0.77
5.87
1.1
1.1
u/ml
1.8
1.2
—
10
48
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
93
368
1.75
5.79
2.0
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
93
368
1.75
5.79
2.0
2.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
92
363
1.75
5.78
1.1
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
117
1278
0.63
5.75
1.2
1.3
u/ml
111.6
122.3
0.65
35
286
(3022806) Fractional oxyhemoglobin in Capillary blood
316
1629
1.34
5.72
1.9
1.9
%
89.0
88.9
0.06
311
1610
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1367
8252
1.15
5.66
3.3
3.8
kpa
5.2
5.1
2.73
1205
7598
(3020779) Urea [Moles/volume] in Serum or Plasma
1491
11657
0.87
5.66
4.3
6.2
mmol/l
11.6
11.6
0.01
1337
10942
(3002385) Erythrocyte distribution width [Ratio]
10657
75922
0.93
5.62
24.6
22.5
%
14.0
14.0
0.57
10337
74129
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
84
985
0.59
5.56
1.7
1.8
mg/l
4.6
4.6
0.03
74
928
(3016038) Potassium [Moles/volume] in Urine
182
857
1.47
5.55
1.1
1.1
mmol/l
33.0
35.3
0.72
146
715
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
12
15
5.52
5.54
8.9
9.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
115
1243
0.64
5.42
1.6
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
94
382
1.70
5.36
2.0
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
45
142
2.19
5.35
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
65
236
1.90
5.34
1.3
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
93
1051
0.61
5.33
1.1
1.2
u/ml
1.6
4.9
3.36
28
347
(3010421) pH of Blood
590
3332
1.23
5.24
3.9
4.2
ph
7.4
7.4
0.76
496
2847
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
34
517
0.45
5.21
1.1
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
227
1132
1.39
5.11
1.4
1.3
mosm/kgh2o
277.2
275.3
0.51
155
839
(3044242) Glucose [Moles/volume] in Arterial blood
140
637
1.52
5.08
1.7
1.9
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
78
908
0.59
5.06
1.0
1.1
%
116.3
115.5
0.09
67
787
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2962
18855
1.10
5.02
1.8
1.9
s
29.6
30.2
4.82
2848
18309
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
226
1130
1.39
5.01
2.3
2.3
u/field
2.6
2.2
0.28
66
402
(3004616) Nuclear Ab [Presence] in Serum
116
1224
0.65
4.93
1.1
1.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
123
548
1.55
4.92
1.7
1.4
umol/l
14.7
14.8
0.05
115
505
(3019550) Sodium [Moles/volume] in Serum or Plasma
15045
102032
1.09
4.89
25.0
21.9
mmol/l
139.7
139.5
9.31
14549
99310
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
188
1810
0.71
4.88
1.4
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
50
650
0.53
4.85
1.2
1.1
u/ml
0.4
1.4
2.19
16
246
(3025130) Human papilloma virus identified in Specimen
37
530
0.48
4.84
1.7
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
147
1474
0.69
4.82
1.2
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
197
1872
0.72
4.73
1.3
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
92
1011
0.63
4.73
1.2
1.2
u/ml
25.5
52.5
—
7
74
(3048929) Epstein Barr virus Ab [Presence] in Serum
161
1577
0.70
4.65
1.1
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2356
17733
0.91
4.64
1.2
1.2
u/ml
1.7
1.8
0.04
544
4094
(3011985) Renin [Units/volume] in Plasma
132
1338
0.68
4.61
1.2
1.4
mu/l
50.1
58.6
0.25
109
1169
(3023103) Potassium [Moles/volume] in Serum or Plasma
15052
102142
1.09
4.61
25.0
22.2
mmol/l
4.0
4.0
2.26
14525
99264
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
3042
19466
1.09
4.59
3.4
3.2
e6/l
3.1
2.5
1.80
1759
10981
(46235355) HIV 1 and 2 tests - Meaningful Use set
1072
8439
0.87
4.53
1.4
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
28
432
0.45
4.52
1.1
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
95
407
1.61
4.51
2.0
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
195
0.28
4.50
1.1
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
515
2918
1.22
4.50
4.0
4.3
mmol/l
2.5
2.8
1.61
364
1995
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
57
211
1.87
4.49
1.1
1.1
—
—
—
0
0
(4306422)
84
930
0.62
4.48
1.2
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
59
713
0.57
4.47
1.0
1.2
%
94.2
92.1
0.26
51
652
(3013290) Carbon dioxide [Partial pressure] in Blood
515
2920
1.22
4.47
4.0
4.3
kpa
5.0
5.0
0.04
496
2845
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
2010
12624
1.11
4.44
3.1
3.1
ng/l
248.6
262.7
0.55
1830
11645
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
876
6986
0.86
4.43
5.5
7.5
mmol/l
24.3
24.4
0.21
777
6436
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
14415
101242
0.93
4.42
10.0
11.8
u/l
22.3
24.0
9.14
13504
96507
(3028717) Thiamine [Mass/volume] in Blood
28
78
2.48
4.42
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
95
1019
0.64
4.41
1.1
1.2
u/ml
3.9
4.4
0.16
35
445
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
123
1250
0.68
4.38
1.1
1.3
pmol/l
265.8
262.2
0.05
88
948
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
22
368
0.41
4.37
1.2
1.4
pmol/l
49.3
136.2
0.59
13
125
(3008401) Mugwort IgE Ab [Units/volume] in Serum
40
538
0.51
4.37
1.1
1.0
u/ml
0.5
1.0
0.93
12
218
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
24
387
0.43
4.36
1.6
1.8
e6/l
1952.9
14946.3
1.81
12
219
(3027008) Opiates [Presence] in Urine
95
412
1.59
4.31
2.0
1.4
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
29
433
0.46
4.31
1.6
1.9
e6/l
454.0
4137.9
1.05
17
296
(4268621)
55
670
0.57
4.31
1.9
2.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
295
2609
0.78
4.30
1.6
1.6
iu/ml
30.1
6.2
0.76
90
654
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
83
348
1.65
4.30
1.1
1.1
ng/l
73.6
431.6
1.37
11
98
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
8261
55009
1.07
4.21
3.2
3.1
u/l
53.2
57.2
2.67
7270
49302
(3028300) Cannabinoids [Presence] in Urine
95
415
1.58
4.19
2.0
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
78
863
0.62
4.18
1.3
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
29
427
0.47
4.16
1.0
1.0
u/ml
0.2
1.3
—
8
102
(3003888) Timothy IgE Ab [Units/volume] in Serum
43
556
0.53
4.16
1.0
1.0
u/ml
0.3
2.8
5.02
13
245
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
229
2083
0.76
4.15
1.2
1.3
u/l
30.5
41.4
1.49
190
1794
(3027315) Oxygen [Partial pressure] in Blood
514
2938
1.21
4.15
4.0
4.3
kpa
8.1
8.4
2.23
494
2863
(3021788) Differential panel - Synovial fluid
245
2205
0.76
4.11
1.5
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
6339
41884
1.07
4.08
3.1
3.2
ng/l
2087.6
1889.6
2.35
5346
36642
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
47
588
0.55
4.07
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
47
587
0.55
4.05
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
47
587
0.55
4.05
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
107
1098
0.67
4.04
1.2
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
122
1221
0.69
4.04
1.2
1.3
nmol/l
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
160
0.26
4.02
1.2
1.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
961
5809
1.15
3.99
2.9
3.9
mmol/l
24.3
24.1
0.90
850
5194
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
47
584
0.55
3.98
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
47
584
0.55
3.98
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
47
583
0.56
3.96
1.1
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
29
87
2.30
3.95
1.1
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
161
1530
0.72
3.95
1.5
1.5
%
66.3
62.7
0.62
107
954
(3003338) MCHC [Mass/volume]
10977
73828
1.06
3.94
27.6
24.8
g/l
330.2
330.8
9.55
10733
73126
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
65
739
0.61
3.94
1.1
1.2
titre
110.0
177.0
—
5
30
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
65
739
0.61
3.94
1.1
1.2
titre
189.3
131.4
0.28
14
133
(40758558) Short blood count panel - Blood
3572
26223
0.93
3.94
5.6
6.7
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
1758
11036
1.11
3.93
4.2
5.8
mmol/l
1.5
1.4
5.68
1676
10575
(3004809) Band form neutrophils/100 leukocytes in Blood
248
2212
0.77
3.91
3.1
3.4
%
2.0
1.4
1.01
184
1697
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
22
350
0.43
3.90
1.0
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
517
2977
1.20
3.89
3.0
3.8
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
22
58
2.62
3.89
1.1
1.2
%
46.9
43.0
0.14
17
33
(3032057) Clostridioides difficile [Presence] in Stool
73
305
1.65
3.88
1.5
1.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
494
2834
1.21
3.87
2.4
2.6
%
16.2
15.8
1.42
235
1562
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1541
9615
1.12
3.86
2.9
3.7
ng/l
89.3
99.4
4.45
1194
8031
(3004716) Salmonella sp identified in Stool by Organism specific culture
558
3239
1.19
3.85
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
87
921
0.65
3.85
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
225
2028
0.76
3.85
1.7
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
122
1209
0.69
3.85
1.3
1.3
u/l
12.4
12.4
0.00
90
959
(3013707) Erythrocyte sedimentation rate by Westergren method
11182
75278
1.06
3.84
3.9
4.4
mm/h
15.4
15.2
0.78
9921
68260
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
14
268
0.36
3.84
1.2
1.3
—
1.5
—
0
37
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
32
102
2.17
3.81
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
127
1247
0.70
3.80
1.1
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
4928
35725
0.94
3.80
2.4
2.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
66
739
0.62
3.77
1.0
1.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
819
4916
1.16
3.77
3.8
4.2
mmol/l
25.1
24.9
1.60
696
4497
(3017354) Segmented neutrophils/100 leukocytes in Blood
145
1387
0.72
3.73
2.9
3.4
%
60.4
59.5
0.14
84
872
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
91
946
0.66
3.71
1.0
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
8636
57733
1.06
3.70
4.1
6.2
umol/l
12.2
12.3
0.14
7938
54739
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
166
0.29
3.68
1.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
150
1421
0.73
3.64
3.1
3.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
86
381
1.56
3.63
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
21
329
0.44
3.61
1.0
1.0
u/ml
1.9
1.8
—
10
132
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
15
270
0.38
3.61
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
15
270
0.38
3.61
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
15
270
0.38
3.61
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
15
270
0.38
3.61
1.1
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
252
2215
0.78
3.57
1.1
1.2
titre
540.0
924.6
—
6
70
(40761511) CBC panel - Blood by Automated count
14350
97450
1.07
3.57
20.2
17.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
161
0.30
3.55
1.9
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
162
0.30
3.55
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
117
1149
0.70
3.54
1.1
1.2
u/ml
282.0
284.1
0.03
66
682
(3000330) Specific gravity of Urine by Test strip
1074
6602
1.13
3.50
4.7
4.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
137
0.25
3.48
1.4
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
44
533
0.57
3.46
1.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
72
310
1.61
3.45
1.1
1.1
u/l
1.1
1.1
0.18
35
167
(3042733) HLA Ab [Presence] in Serum
6
149
0.28
3.43
4.7
4.7
—
—
—
0
0
(3024471) HLA-A [Type]
8
170
0.32
3.39
1.0
1.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1893
12021
1.10
3.38
4.8
6.9
g/l
120.3
119.3
1.45
1830
11577
(3014133) Dog dander IgE Ab [Units/volume] in Serum
25
357
0.48
3.36
1.0
1.0
u/ml
0.9
2.0
0.61
12
145
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
226
1208
1.29
3.36
1.8
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
316
1761
1.24
3.33
1.6
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
202
1805
0.77
3.30
1.6
1.5
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
7
154
0.31
3.28
3.7
1.4
pmol/l
74.1
60.6
—
7
117
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
47
549
0.59
3.25
2.0
2.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
314
2660
0.81
3.24
2.2
2.7
mg/l
1.8
1.8
0.45
259
2345
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
31
406
0.53
3.22
1.0
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
253
2190
0.79
3.19
1.1
1.1
titre
85.8
138.8
1.41
19
159
(3038177) Helicobacter pylori Ab [Presence] in Serum
119
1140
0.72
3.16
1.6
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
395
3260
0.83
3.13
1.3
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
24
74
2.24
3.13
1.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
174
0.36
3.12
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
174
0.36
3.12
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
175
0.35
3.12
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
175
0.35
3.12
1.3
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
54
600
0.62
3.06
1.0
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
86
865
0.68
3.03
2.2
1.9
e9/l
1.1
1.1
0.04
54
528
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
107
1034
0.71
3.01
1.6
1.8
pmol/l
173.8
188.7
0.99
91
942
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
149
0.32
3.00
1.1
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
30
387
0.53
2.99
2.3
1.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
79
805
0.68
2.99
1.5
1.4
iu/l
40.2
33.4
0.75
64
677
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
86
862
0.69
2.98
1.2
1.2
mmol/l
7.8
8.0
0.22
66
561
(40768806) Pleura Pathology biopsy report
205
1802
0.78
2.98
1.4
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
21
303
0.48
2.96
1.3
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
62
660
0.65
2.92
1.3
1.6
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
10
194
0.36
2.90
2.8
2.5
u/l
753.1
1168.1
—
10
181
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
121
604
1.39
2.89
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
144
0.34
2.87
1.1
1.4
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
62
657
0.65
2.87
1.1
1.1
—
36.6
—
0
5
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
11
23
3.30
2.86
1.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
28
363
0.53
2.85
1.3
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
26
343
0.52
2.81
1.8
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
63
660
0.66
2.77
1.0
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
51
559
0.63
2.77
1.8
2.1
ml
1723.3
1817.4
0.21
36
465
(3027944) Amphetamines [Presence] in Urine
85
402
1.46
2.75
2.1
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
158
830
1.32
2.74
7.2
12.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
466
3743
0.86
2.73
1.9
2.4
g/l
0.0
0.0
0.00
395
3417
(3005033) Fetal Nuchal fold Thickness US
7
143
0.34
2.72
1.1
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
141
1283
0.76
2.71
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
84
828
0.70
2.70
1.2
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
138
1257
0.76
2.68
1.1
1.2
u/l
61.0
61.1
0.01
82
825
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
186
0.37
2.68
1.2
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
3196
20915
1.07
2.65
3.1
3.0
e6/l
1.5
1.4
0.59
1886
12356
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
22
71
2.14
2.62
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
18
260
0.48
2.59
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
34
403
0.58
2.56
1.2
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
516
3093
1.16
2.54
2.1
2.3
g/l
127.5
126.2
0.48
403
2246
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
62
638
0.67
2.53
2.1
1.8
%
14.9
15.9
0.20
29
231
(36660697) Celiac disease serology panel - Serum
844
6480
0.89
2.52
1.2
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
15
229
0.45
2.52
4.7
8.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
33
392
0.58
2.52
1.8
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1636
10469
1.09
2.51
1.7
2.1
g/l
0.2
0.2
0.39
1424
9658
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
31
374
0.57
2.51
7.5
3.5
u/ml
49.7
55.2
—
7
40
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
10
179
0.39
2.48
12.2
12.6
mmol/l
5.8
5.0
—
10
179
(3012441) Differential panel - Pleural fluid
209
1789
0.80
2.48
1.4
1.5
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
123
0.34
2.47
1.5
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
135
0.36
2.47
1.4
1.5
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
22
73
2.08
2.46
1.0
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
221
1879
0.81
2.46
1.3
1.5
e6/l
68902.5
61375.3
0.14
142
1098
(40765096) Chromosome analysis panel by Banding
30
363
0.57
2.46
1.1
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
47
200
1.62
2.46
1.0
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
63
288
1.51
2.44
1.3
1.5
pmol/l
16.1
17.2
0.69
47
230
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
71
706
0.69
2.43
2.0
2.2
ug/min
388.6
112.0
0.37
16
172
(21494890) Protein electrophoresis panel - 24 hour Urine
173
1509
0.79
2.43
1.6
2.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
283
2344
0.83
2.42
1.3
1.5
g/l
30.1
31.4
1.08
257
2081
(1175426) CD3 cells/100 lymphocytes in Blood
65
656
0.68
2.41
2.0
1.8
%
71.8
70.0
0.34
59
615
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
480
3807
0.87
2.41
1.9
2.4
g/l
0.0
0.0
0.05
396
3428
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
69
688
0.69
2.40
4.0
5.0
u/ml
22.7
112.9
3.02
14
205
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
16
47
2.35
2.36
1.4
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
130
1169
0.77
2.35
1.2
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
933
5837
1.11
2.34
3.5
3.9
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
28
340
0.57
2.34
2.4
1.8
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
32
124
1.78
2.34
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
451
3582
0.87
2.33
1.6
1.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
360
2906
0.85
2.30
1.6
1.6
e6/l
20441.6
14401.0
0.99
259
2056
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
35
399
0.60
2.30
2.4
2.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
578
3523
1.14
2.28
2.6
3.1
mmol/l
25.0
25.0
0.12
510
3085
(3028679) Herpes simplex virus Ab [Presence] in Serum
61
282
1.49
2.26
1.1
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
14
209
0.46
2.25
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
125
1122
0.77
2.24
1.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
62
621
0.69
2.24
2.2
1.8
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
56
571
0.68
2.22
1.2
1.5
%
4.9
3.4
0.40
17
128
(21494815) CD4 cells/100 lymphocytes in Specimen
72
701
0.71
2.22
2.1
1.9
%
43.8
38.8
0.65
11
83
(3024139) IgG subclass 3 [Mass/volume] in Serum
91
853
0.74
2.22
1.2
1.4
g/l
0.4
0.4
0.03
64
590
(3027135) IgG subclass 1 [Mass/volume] in Serum
91
853
0.74
2.22
1.2
1.4
g/l
7.4
7.2
0.14
61
586
(3028192) IgG subclass 2 [Mass/volume] in Serum
91
853
0.74
2.22
1.2
1.4
g/l
2.8
2.9
0.48
64
588
(3008536) Aspergillus sp Ab [Presence] in Serum
15
217
0.48
2.21
1.1
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
73
708
0.71
2.20
1.5
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
14
207
0.47
2.19
1.8
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
46
486
0.65
2.19
1.1
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
71
690
0.71
2.17
1.4
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
71
690
0.71
2.17
1.4
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
518
4051
0.88
2.16
1.9
2.3
g/l
0.1
0.0
0.11
432
3659
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
20
68
2.03
2.14
1.6
1.7
mmol/l
2.2
0.9
—
9
41
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
473
3716
0.88
2.12
1.1
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
23
285
0.56
2.10
1.0
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
2242
16363
0.94
2.08
1.9
2.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
26
99
1.81
2.04
1.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
52
527
0.68
2.03
4.7
6.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
22
273
0.56
2.03
4.9
8.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
219
1248
1.21
2.02
2.7
2.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
211
1760
0.83
2.01
1.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
51
234
1.51
2.00
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
242
1991
0.84
1.99
2.6
3.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
27
105
1.78
1.99
1.1
1.1
—
—
—
0
0
(4062490)
93
852
0.75
1.98
1.2
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
660
5053
0.90
1.95
2.5
2.7
u/ml
0.4
0.3
0.34
381
2880
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
88
810
0.75
1.94
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
56
554
0.70
1.94
1.3
1.6
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
36
389
0.64
1.94
1.0
1.1
iu/ml
11.2
12.1
—
8
83
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
46
208
1.53
1.93
1.2
1.1
miu/ml
1745.2
1621.7
0.25
46
208
(3033799) Differential panel - Peritoneal fluid
34
372
0.63
1.93
1.7
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
217
1797
0.83
1.93
1.2
1.4
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
78
730
0.74
1.93
1.1
1.1
u/ml
3.7
4.4
0.13
15
160
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
197
1646
0.82
1.93
1.2
1.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
66
634
0.72
1.93
1.1
1.1
u/l
28.8
31.0
0.13
45
455
(3045788) Cell count panel - Pleural fluid
187
1570
0.82
1.92
1.4
1.5
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
66
633
0.72
1.91
1.1
1.1
u/l
76.8
91.9
1.01
50
471
(3000093) Morphology [Interpretation] in Blood Narrative
152
1301
0.80
1.89
1.1
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
18
62
2.00
1.88
1.0
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
1877
12216
1.07
1.88
2.1
2.5
e9/l
65.0
67.7
2.75
1466
9302
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
176
0.47
1.88
1.0
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
140
768
1.26
1.86
2.2
2.4
ph
7.4
7.4
0.08
30
314
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
189
1578
0.82
1.85
1.2
1.4
u/l
355.1
432.3
0.59
175
1494
(3026726) Creatinine [Moles/volume] in Specimen
7
118
0.41
1.83
3.4
2.3
umol/l
191.1
378.4
—
7
109
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
117
630
1.28
1.81
1.2
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
117
630
1.28
1.81
1.2
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
51
506
0.69
1.81
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
108
0.38
1.81
1.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
84
767
0.75
1.78
2.9
3.7
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
16
54
2.05
1.77
1.6
1.5
mmol/l
25.3
22.5
—
10
30
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
13
181
0.50
1.77
5.2
7.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
222
1814
0.84
1.74
1.8
2.2
pg
33.0
32.6
0.76
217
1804
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
78
716
0.75
1.73
1.2
1.2
u/l
107.9
94.1
0.35
67
616
(3009871) Measles virus Ab [Titer] in Serum
8
127
0.43
1.73
1.8
1.7
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
127
0.43
1.73
1.3
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
37
386
0.66
1.72
1.5
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
19
232
0.56
1.70
1.1
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
315
1886
1.16
1.70
1.1
1.1
u/ml
5.7
13.3
—
8
90
(3036071) Salmonella sp Ab [Titer] in Serum
14
187
0.52
1.69
1.2
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
132
1130
0.80
1.68
1.4
1.5
%
19.2
27.7
3.11
87
696
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
19
70
1.87
1.68
1.1
1.1
mmol/l
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
18
222
0.56
1.68
1.2
1.1
%
77.2
80.5
—
5
112
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
92
0.37
1.67
1.0
1.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
255
2050
0.86
1.65
1.3
1.5
e6/l
3161.9
2262.9
0.46
192
1475
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
64
600
0.74
1.65
2.0
2.1
e6/l
709.6
564.8
0.74
24
268
(3045424) Erythrocytes [Presence] in Urine
227
1840
0.85
1.63
1.5
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
36
161
1.54
1.63
3.5
2.7
u/field
0.5
0.5
0.19
36
161
(3011648) Oxygen content in Venous blood
91
810
0.77
1.63
1.3
1.7
%
9.5
10.8
1.99
91
810
(40761536) Microorganisms panel - Urine sediment
1393
9026
1.07
1.63
5.3
4.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
166
0.50
1.62
1.0
1.0
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
5
9
3.84
1.62
1.0
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
19
228
0.57
1.61
1.1
1.3
%
109.8
114.4
0.30
13
196
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
18
219
0.57
1.61
1.2
1.2
%
94.4
79.6
—
5
113
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
7
110
0.44
1.59
1.0
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
643
4869
0.91
1.59
2.2
3.2
mg/l
56.1
81.1
1.11
498
3962
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
60
564
0.73
1.59
2.0
2.0
e6/l
406.8
514.3
1.34
52
480
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
231
1864
0.85
1.58
1.3
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
642
4857
0.91
1.56
2.2
3.2
mg/l
45.9
49.8
0.29
501
3953
(3021901) Oxygen saturation in Capillary blood
433
2666
1.12
1.56
2.4
2.9
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
1080
7991
0.93
1.55
5.5
7.6
%
92.9
93.7
3.76
1071
7961
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
32
0.00
1.55
0.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
53
505
0.72
1.54
1.1
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
89
0.39
1.54
1.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
55
520
0.73
1.52
1.6
1.4
u/l
5.2
6.5
1.81
42
419
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
14
48
2.01
1.51
1.6
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
26
283
0.63
1.51
3.3
2.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
26
283
0.63
1.51
2.3
2.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
7
18
2.68
1.50
1.0
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
151
1256
0.83
1.49
1.2
1.3
u/l
21.8
12.3
1.53
132
1152
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
193
1126
1.19
1.48
1.7
1.6
u/ml
30.1
25.9
0.59
46
230
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
152
1261
0.83
1.46
1.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
19
221
0.59
1.46
1.2
2.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
15122
103515
1.04
1.46
29.6
27.1
e9/l
7.2
7.0
17.34
14451
99669
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
46
443
0.72
1.44
1.8
1.9
u/ml
1029.5
1595.7
1.37
46
429
(3014576) Chloride [Moles/volume] in Serum or Plasma
2409
15927
1.05
1.44
4.6
6.2
mmol/l
104.5
104.3
1.43
2318
15572
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
78
694
0.77
1.43
1.2
1.2
u/l
40.5
27.8
0.74
61
587
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
16
193
0.57
1.42
1.3
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
90
488
1.27
1.39
1.2
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
26
277
0.65
1.39
1.3
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
255
2018
0.87
1.39
1.6
1.6
iu/l
2.9
4.8
5.55
68
578
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
690
5165
0.92
1.36
2.0
2.3
g/l
3.1
3.1
0.16
467
3960
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
139
1153
0.83
1.36
1.1
1.1
iu/ml
58.0
431.2
0.85
23
201
(3016750) Collection duration of Urine
87
758
0.79
1.36
1.9
2.0
min
515.6
496.8
1.20
59
537
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
29
0.00
1.36
0.0
1.0
—
0.1
—
0
19
(3007461) Platelets [#/volume] in Blood
15111
103484
1.04
1.34
29.5
27.1
e9/l
236.5
238.7
3.34
14505
100070
(3026361) Erythrocytes [#/volume] in Blood
15113
103501
1.04
1.33
29.5
27.1
e12/l
4.3
4.4
117.39
14439
99615
(3035941) MCH [Entitic mass]
15112
103496
1.04
1.33
29.4
27.0
pg
30.4
30.4
0.53
14641
101446
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4203
29860
0.96
1.33
2.7
3.1
u/l
34.7
36.6
0.56
3869
27927
(3044927) Protein electrophoresis panel - Urine
255
1537
1.15
1.32
1.2
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
15112
103498
1.04
1.32
29.4
27.0
fl
92.0
91.9
2.49
14646
101445
(3000963) Hemoglobin [Mass/volume] in Blood
15114
103513
1.04
1.32
29.8
27.3
g/l
128.4
131.8
132.19
14643
101474
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
15
180
0.57
1.32
1.7
4.4
u/l
41.0
42.9
—
10
64
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
9
123
0.50
1.32
1.0
3.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1356
9891
0.94
1.31
2.2
2.4
u/l
35.9
48.8
0.88
1104
8402
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
261
2052
0.88
1.31
1.2
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
85
738
0.79
1.30
1.6
1.5
u/l
4.3
7.5
1.43
38
338
(4015189)
42
402
0.72
1.30
1.6
2.3
—
—
—
0
0
(44813793)
53
488
0.75
1.28
1.0
1.1
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
8
110
0.50
1.28
1.3
1.6
mmol/l
2.0
2.8
—
8
91
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
23
246
0.64
1.28
1.0
1.1
%
93.6
92.7
0.05
18
175
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
106
895
0.82
1.26
1.1
1.1
iu/ml
0.9
2.3
—
6
45
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
750
5574
0.93
1.26
1.9
2.3
g/l
3.9
3.8
0.45
460
3891
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
705
5251
0.92
1.26
1.9
2.3
g/l
10.2
10.3
0.22
519
4320
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2677
19161
0.96
1.23
2.2
2.8
mmol/l
0.8
0.8
0.14
2347
17607
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
35
342
0.71
1.23
2.3
2.0
u/l
14.7
44.2
2.93
30
321
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
753
5584
0.93
1.21
1.9
2.3
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
22
95
1.60
1.20
14.7
11.5
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
27
275
0.68
1.20
1.4
1.3
g/l
24.5
49.3
0.64
20
222
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
90
0.46
1.19
1.3
1.7
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
24
0.00
1.19
0.0
1.6
—
1.7
—
0
14
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
139
0.55
1.18
1.5
1.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
492
3106
1.10
1.18
2.5
3.0
kpa
7.5
7.8
3.76
456
2873
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
627
4677
0.92
1.18
1.9
2.5
g/l
1.2
1.1
0.13
468
3916
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
633
4719
0.92
1.17
2.2
3.2
ratio
1.9
5.4
1.36
41
335
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
755
5589
0.93
1.17
1.9
2.3
g/l
7.5
7.5
0.11
473
4047
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
79
0.44
1.16
1.6
4.4
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
31
303
0.71
1.12
1.3
1.4
g/l
13.8
15.3
0.37
21
235
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2259
16188
0.96
1.12
3.9
5.3
mmol/l
1.0
1.0
1.76
1968
14778
(3036782) Glucose [Moles/volume] in Pleural fluid
188
1490
0.87
1.11
1.2
1.4
mmol/l
6.0
6.4
1.07
169
1384
(4146454)
189
1496
0.87
1.09
2.5
2.7
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
136
796
1.18
1.08
1.9
2.2
mmol/l
7.8
7.2
1.14
98
536
(3035933) Granulocytes/100 leukocytes in Blood
10
126
0.55
1.08
1.4
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
239
1860
0.89
1.07
1.4
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2466
17622
0.96
1.07
2.3
2.6
%
20.6
21.1
1.08
1863
14868
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
88
0.47
1.07
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
272
2099
0.89
1.06
1.3
1.5
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
12
45
1.84
1.06
1.0
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
25
251
0.69
1.06
1.3
1.1
umol/24h
0.6
0.7
0.10
12
109
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
10
35
1.97
1.06
1.0
1.1
—
33.0
—
0
10
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
982
7171
0.94
1.04
2.5
2.6
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
117
956
0.84
1.04
1.7
1.9
ug/l
3.1
4.1
0.97
101
825
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
5
77
0.45
1.03
1.0
1.4
—
27521.6
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
149
0.60
1.01
1.1
1.1
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
9
111
0.56
1.01
1.4
1.3
—
743.8
—
0
13
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
21
0.00
1.00
0.0
1.5
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
21
0.00
1.00
0.0
1.1
—
1922.9
—
0
21
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
11
41
1.85
0.99
1.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
89
741
0.83
0.98
1.3
1.5
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
23
0.00
0.97
0.0
1.1
—
8.3
—
0
23
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
29
278
0.72
0.97
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
817
5981
0.94
0.96
2.6
2.9
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
13
52
1.73
0.96
1.3
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
90
746
0.83
0.96
1.1
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
138
0.60
0.95
1.5
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
217
1683
0.89
0.95
1.2
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
944
6876
0.94
0.94
5.9
8.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
17
179
0.66
0.93
1.1
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
18
187
0.66
0.93
1.1
1.2
—
1484.4
—
0
9
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
28
267
0.72
0.91
1.2
1.1
pmol/l
270.5
277.4
0.04
15
183
(3029634) Reagin Ab [Titer] in Serum by VDRL
133
791
1.16
0.91
1.4
1.6
—
2.7
—
0
12
(3025018) Bordetella pertussis Ab [Titer] in Serum
36
329
0.75
0.90
1.2
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
40
360
0.77
0.89
1.1
1.1
ratio
1.1
1.1
0.29
11
108
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
130
1037
0.86
0.89
1.2
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
130
1037
0.86
0.89
1.2
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
130
1037
0.86
0.89
1.2
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
90
738
0.84
0.87
1.3
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
13
54
1.66
0.86
1.3
1.8
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
11
125
0.61
0.85
1.7
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
139
1098
0.87
0.84
2.0
2.2
ml
654.1
649.7
0.04
79
705
(3048879) Bone marrow aspiration report
53
456
0.80
0.84
1.2
1.5
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
65
546
0.82
0.83
1.4
1.4
%
3.1
2.4
0.24
49
451
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
75
429
1.21
0.82
1.9
1.9
nmol/l
13.9
14.3
0.17
65
391
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
3107
21992
0.97
0.81
1.6
1.7
mg/l
1.6
1.5
0.61
2407
17255
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
58
492
0.81
0.81
1.2
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
58
492
0.81
0.81
1.2
1.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
17
0.00
0.81
0.0
3.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
17
0.00
0.81
0.0
6.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
336
2521
0.92
0.81
1.6
1.6
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
18
0.00
0.81
0.0
1.0
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
12
131
0.63
0.80
1.0
1.1
iu/ml
3.7
21.9
—
6
49
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
23
220
0.72
0.79
2.0
1.6
ug/l
9.6
9.8
0.09
23
220
(40762814) Titanium [Mass/volume] in Blood
30
275
0.75
0.79
1.9
2.2
ug/l
3.3
3.5
0.18
14
108
(3027923) C peptide [Moles/volume] in Serum or Plasma
85
495
1.19
0.78
1.2
1.3
nmol/l
1.1
1.1
0.01
57
374
(3018291) Platelet Ab [Presence] in Serum
0
20
0.00
0.78
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
28
142
1.36
0.78
1.2
1.1
umol/l
16.5
16.4
0.05
23
128
(3016650) Hepatitis A virus Ab [Presence] in Serum
151
1178
0.88
0.78
1.1
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
58
488
0.82
0.76
2.3
2.6
%
42.3
36.6
0.77
21
179
(44816559) Phosphatidylethanol [Mass/volume] in Blood
141
1103
0.88
0.76
1.2
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
38
335
0.78
0.76
1.1
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
90
529
1.18
0.75
1.1
1.1
—
—
—
0
0
(3025315) Body weight
8
93
0.59
0.75
7.6
5.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
590
4320
0.94
0.75
1.8
2.3
g/l
36.5
36.8
0.63
430
3611
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
153
936
1.13
0.75
1.2
1.3
titre
206.8
390.7
0.90
25
91
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
107
850
0.87
0.73
1.1
1.2
miu/ml
155.9
214.1
0.53
13
230
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
320
2392
0.92
0.73
1.5
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
62
515
0.83
0.73
1.2
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
117
922
0.88
0.72
1.7
2.0
ug/l
1.8
2.3
1.64
91
763
(40760888) Immunoglobulin light chains.free panel - Serum
492
3615
0.94
0.71
2.3
3.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
21
199
0.73
0.70
1.2
1.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
27
139
1.34
0.70
1.2
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
4868
34175
0.98
0.70
4.4
5.1
%
21.6
22.5
4.13
2487
19060
(3043410) Blood group antigens tested for on Red Blood Cells
41
353
0.80
0.69
1.6
1.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
948
6832
0.96
0.68
1.4
1.6
g/l
1.6
1.6
0.56
740
5827
(3020961) Endomysium IgA Ab [Titer] in Serum
447
3288
0.94
0.68
1.1
1.1
titre
219.1
220.2
0.00
16
62
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
114
690
1.14
0.68
2.4
2.0
u/field
2.6
2.5
0.09
71
458
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
39
336
0.80
0.67
1.1
1.2
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
29
259
0.77
0.66
1.6
1.6
ug/l
110.2
115.8
0.09
24
218
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
62
509
0.84
0.66
1.2
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
7
30
1.61
0.65
1.9
1.0
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
54
448
0.83
0.65
1.2
1.2
g/l
38.9
40.0
0.31
30
216
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
77
619
0.86
0.64
1.3
1.4
%
58.6
67.1
1.11
54
501
(3000991) Gas panel - Venous blood
1489
10615
0.97
0.64
4.8
7.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
74
596
0.86
0.64
4.5
4.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
26
234
0.77
0.63
1.3
1.2
mu/l
48.0
81.8
1.10
16
167
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
79
632
0.86
0.63
1.2
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
79
632
0.86
0.63
1.2
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
79
632
0.86
0.63
1.2
1.6
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
46
386
0.82
0.63
1.3
1.3
u/l
36.1
33.6
0.17
31
318
(4024509)
200
1259
1.10
0.62
1.5
1.7
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
14
0.00
0.62
0.0
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
147
911
1.11
0.62
1.2
1.3
titre
30.0
69.2
—
8
76
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
61
497
0.85
0.61
1.3
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
41
229
1.24
0.61
2.8
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
111
865
0.89
0.61
1.2
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
18
89
1.40
0.60
1.1
1.1
—
—
—
0
0
(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma
0
16
0.00
0.60
0.0
1.1
—
171.8
—
0
11
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
8
36
1.53
0.59
1.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
26
231
0.78
0.59
1.1
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
245
1827
0.92
0.57
1.3
1.3
nmol/l
0.9
0.8
0.54
187
1489
(3030905) Polymorphonuclear cells [#/volume] in Blood
265
1970
0.93
0.57
2.8
3.3
e9/l
4.7
4.4
0.77
265
1964
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
27
145
1.29
0.56
1.2
1.0
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
16
151
0.73
0.55
1.1
1.2
mmol/l
7.1
6.5
—
6
66
(3037756) Immunofixation for Serum or Plasma
438
3196
0.94
0.55
1.3
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
192
1442
0.92
0.54
3.6
3.8
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
6
26
1.59
0.54
1.5
1.5
nmol/l
503.6
397.6
—
6
26
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
26
1.59
0.54
1.0
1.3
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
51
296
1.19
0.54
2.5
2.6
mmol/l
7.4
7.9
0.56
37
192
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1692
11992
0.97
0.54
2.1
2.6
umol/l
9.6
9.9
0.21
1404
10461
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
9
93
0.67
0.53
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
247
1830
0.93
0.51
1.2
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
80
627
0.88
0.51
3.0
3.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
467
3391
0.95
0.51
1.7
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
11
109
0.70
0.51
1.2
1.6
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
106
656
1.12
0.49
2.0
2.0
umol/l
16.1
29.0
0.97
11
65
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
36
300
0.83
0.49
1.1
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
57
455
0.86
0.48
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
45
366
0.85
0.48
1.6
1.5
nmol/l
0.2
0.2
0.84
33
264
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
81
630
0.89
0.47
1.2
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
99
0.70
0.47
1.6
1.5
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
153
1149
0.92
0.46
1.6
1.9
g/24h
1.5
0.7
—
7
37
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
369
2686
0.95
0.46
1.3
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
121
759
1.10
0.45
1.1
1.2
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
64
503
0.88
0.45
1.3
1.3
ug/l
1109.2
195.7
0.88
37
274
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
24
206
0.80
0.44
1.7
1.5
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
18
160
0.78
0.44
1.0
1.2
u/l
13.5
17.8
—
10
115
(3014891) Appearance of Pleural fluid
43
252
1.18
0.44
1.6
1.6
—
—
—
0
0
(4133840)
19
167
0.79
0.43
1.4
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2658
18660
0.98
0.42
2.1
2.6
g/l
2.2
2.3
3.72
2295
17124
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
12
0.00
0.42
0.0
1.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
12
0.00
0.42
0.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
92
703
0.90
0.41
1.6
1.7
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
153
1141
0.92
0.41
1.3
1.4
u/l
13.6
13.4
0.12
143
1093
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
58
455
0.88
0.41
2.3
2.7
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
13
0.00
0.40
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
62
484
0.88
0.40
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
71
0.68
0.40
1.1
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
71
0.68
0.40
1.1
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
14
127
0.76
0.40
1.6
1.5
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
7
72
0.67
0.40
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
385
2535
1.05
0.40
2.4
2.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
165
1059
1.08
0.39
1.3
1.5
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
18
97
1.28
0.39
1.6
1.7
%
1.1
0.8
0.13
13
77
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
58
353
1.13
0.38
1.5
1.7
nmol/l
6.6
5.3
0.16
53
305
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
8
79
0.70
0.38
1.6
1.3
—
—
—
0
0
(4211845)
84
640
0.91
0.37
4.4
3.9
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1127
7971
0.97
0.36
5.3
7.5
%
0.7
0.7
7.25
1113
7911
(3050794) Legionella sp Ab [Presence] in Serum
9
85
0.73
0.36
1.1
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
37
219
1.17
0.36
1.1
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
12
109
0.76
0.35
1.0
1.1
umol/24h
1.7
1.7
0.04
12
109
(3014051) Protein [Presence] in Urine by Test strip
359
2585
0.96
0.33
2.6
2.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
96
608
1.09
0.33
2.0
2.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
1132
7992
0.98
0.32
5.3
7.4
%
1.5
1.3
6.12
1118
7931
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
132
849
1.07
0.32
1.2
1.2
nmol/l
1.1
1.5
3.78
120
761
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
268
1763
1.05
0.32
2.1
2.2
mg/l
29.1
28.2
0.08
72
425
(3027974) Hepatitis B virus e Ag [Presence] in Serum
7
35
1.38
0.32
1.4
1.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
7
35
1.38
0.32
1.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
20
113
1.22
0.31
1.5
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
56
429
0.90
0.30
1.2
1.5
umol/l
18.4
11.5
0.32
43
295
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
67
420
1.10
0.30
1.7
1.9
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
11
98
0.77
0.29
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
192
1398
0.95
0.29
3.4
3.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
11825
81299
1.01
0.29
22.6
20.2
%
36.4
37.9
25.02
6071
47860
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1017
7173
0.98
0.29
4.5
6.1
mmol/l
24.8
24.8
0.10
999
7096
(4212803)
18
150
0.83
0.28
1.1
1.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
2928
19973
1.01
0.28
2.2
2.6
umol/l
11.1
11.8
5.42
2520
18322
(3037121) Protein [Mass/volume] in Urine
638
4285
1.03
0.28
2.4
2.9
g/l
0.3
0.3
0.42
216
1772
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
10
52
1.33
0.28
1.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
82
0.76
0.28
1.1
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
9
82
0.76
0.28
1.0
1.0
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
25
147
1.17
0.28
1.1
1.3
ng/l
3573.6
208.9
0.48
16
94
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
31
245
0.87
0.27
1.4
1.4
ng/l
112.0
131.1
0.59
31
245
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
57
433
0.91
0.27
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
57
433
0.91
0.27
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
16
90
1.23
0.27
1.1
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
16
90
1.23
0.27
1.1
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
16
90
1.23
0.27
1.1
1.1
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
12
65
1.27
0.26
2.0
1.2
u/field
1.2
1.0
—
6
38
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
34
266
0.88
0.26
1.4
1.5
%
11.1
10.0
0.06
13
132
(3004588) Protein electrophoresis panel - Serum or Plasma
1436
9749
1.02
0.26
1.9
2.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
71
532
0.92
0.26
1.0
1.0
mg/l
294.6
291.3
0.14
57
467
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
188
1362
0.95
0.25
1.3
1.5
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
47
293
1.11
0.24
1.4
1.5
ug/l
0.4
0.4
0.01
22
169
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
63
399
1.09
0.24
4.6
5.4
%
61.2
72.9
2.05
48
309
(3006245) CD3-CD19+ cells/100 cells in Blood
33
257
0.89
0.24
1.9
1.9
%
10.0
12.1
0.24
27
227
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
27
213
0.87
0.24
1.2
1.1
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
59
373
1.09
0.24
1.3
1.4
%
76.9
59.7
4.93
41
322
(3021387) Prolactin [Units/volume] in Serum or Plasma
146
1062
0.95
0.24
2.3
1.7
mu/l
350.7
301.8
0.74
134
975
(3013512) EKG study
5113
35546
0.99
0.24
4.7
4.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
93
600
1.07
0.24
1.4
1.6
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
5
26
1.33
0.23
1.2
1.4
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
14
79
1.22
0.23
1.1
1.1
u/field
0.9
1.1
—
7
50
(3024869) Neuronal Ab [Presence] in Serum
38
235
1.12
0.23
1.0
1.1
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
5
27
1.28
0.23
1.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(40759632) Porphyrins [Mass/mass] in Stool
0
7
0.00
0.22
0.0
1.1
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
7
0.00
0.22
0.0
1.3
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
8
0.00
0.22
0.0
1.1
—
—
—
0
0
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
0
8
0.00
0.22
0.0
1.4
—
—
—
0
0
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
8
0.00
0.22
0.0
6.8
—
8.9
—
0
8
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
9
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
0
9
0.00
0.21
0.0
6.8
—
6.5
—
0
9
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
37
283
0.90
0.21
1.2
1.2
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
39
297
0.91
0.21
1.1
1.2
mmol/l
1.4
1.5
0.15
26
184
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
823
5575
1.02
0.21
2.3
2.4
au/ml
46.1
28.6
0.67
12
151
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
440
3117
0.97
0.21
2.0
2.3
ug/min
125.9
104.5
0.37
218
1774
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.20
0.0
1.0
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
10
0.00
0.20
0.0
1.0
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.20
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
19
113
1.16
0.20
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
63
467
0.93
0.19
1.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
47
298
1.09
0.19
1.3
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
110
799
0.95
0.19
1.2
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
84
615
0.94
0.19
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
7
40
1.21
0.18
1.9
2.6
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
32
243
0.91
0.17
3.2
2.8
ml/dl
15.3
14.7
0.61
26
227
(3022493) Free Hemoglobin [Mass/volume] in Plasma
65
478
0.94
0.17
1.1
3.1
mg/l
64.3
73.8
0.54
37
330
(40765089) Chromosome analysis panel - Blood by G-banded
5
48
0.72
0.17
1.2
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
28
214
0.90
0.17
1.3
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
213
1516
0.97
0.15
1.3
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
213
1426
1.03
0.15
1.4
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
47
348
0.93
0.15
1.4
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
21
162
0.89
0.15
2.9
2.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
18
140
0.89
0.14
1.7
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
111
735
1.04
0.14
3.3
3.9
—
—
—
0
0
(44806071)
13
77
1.17
0.14
1.2
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
32
240
0.92
0.14
1.1
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
715
5007
0.99
0.14
1.3
1.3
au/ml
43.7
59.2
1.07
29
207
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
67
0.82
0.14
1.0
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
160
1141
0.97
0.14
1.2
1.4
e6/l
96498.7
176338.5
0.94
100
786
(44806118)
160
1141
0.97
0.14
1.3
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
8
68
0.81
0.14
1.0
1.2
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
8
68
0.81
0.14
3.1
3.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
1673
11650
0.99
0.13
2.0
2.6
g/l
65.2
65.9
2.71
1376
10412
(3035880) pH of Pleural fluid
128
916
0.96
0.13
1.2
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
479
3364
0.98
0.13
1.4
1.4
ug/g
272.1
260.0
0.66
262
2095
(3046861) Legionella sp Ag [Presence] in Urine
12
71
1.17
0.13
1.0
1.1
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
75
543
0.95
0.13
1.2
1.2
u/l
178.2
313.4
1.44
70
499
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
14
110
0.88
0.13
1.3
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
116
773
1.04
0.12
3.2
2.6
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
90
597
1.04
0.11
1.8
2.2
mmol/l
9.4
9.0
0.38
69
447
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
14
85
1.14
0.11
1.1
1.1
u/l
10.1
9.2
0.12
14
85
(3000285) Sodium [Moles/volume] in Blood
29
185
1.08
0.11
1.5
1.2
—
—
—
0
0
(44790048)
161
1141
0.97
0.11
1.2
1.4
—
—
—
0
0
(44790049)
161
1141
0.97
0.11
1.2
1.4
—
—
—
0
0
(44790047)
161
1141
0.97
0.11
1.2
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
12
94
0.88
0.10
1.5
1.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
14638
101152
0.99
0.10
23.3
22.0
umol/l
85.4
85.5
0.10
14631
101100
(3024522) Salmonella sp identified in Specimen by Organism specific culture
217
1530
0.98
0.10
1.3
1.4
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
5
31
1.11
0.10
1.2
2.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
88
629
0.97
0.10
1.2
1.2
mmol/l
11.5
12.1
0.28
30
194
(44786800) Granulocytes/100 leukocytes in Body fluid
35
227
1.06
0.10
1.3
1.4
%
22.6
21.6
0.06
22
176
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
5
33
1.05
0.09
1.0
1.1
—
0.1
—
0
14
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
30
221
0.94
0.09
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
243
1647
1.02
0.09
1.3
1.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
37
270
0.95
0.09
5.5
5.9
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
10
60
1.15
0.09
1.1
1.4
—
—
—
0
0
(44806420)
72
479
1.04
0.09
2.4
2.5
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
18
135
0.92
0.08
2.0
2.0
ug/l
3.8
5.8
0.30
11
79
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
6
50
0.83
0.08
8.5
8.2
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
6
50
0.83
0.08
1.2
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
34
247
0.95
0.07
1.2
1.2
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
9
58
1.07
0.07
1.2
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
100
673
1.03
0.07
2.0
2.2
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
20
148
0.93
0.07
1.0
1.6
—
46.8
—
0
10
(3004451) EKG impression Narrative
102
721
0.98
0.06
1.2
1.3
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
11
68
1.12
0.06
1.0
1.2
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
29
211
0.95
0.06
1.0
1.3
u/l
37.9
378.0
0.86
19
146
(3002619) Bacteria identified in Specimen by Culture
33
239
0.95
0.06
1.2
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
71
476
1.03
0.06
1.8
1.7
u/l
2552.3
1146.6
0.30
18
174
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
363
2482
1.01
0.05
1.3
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
23
150
1.06
0.05
1.3
1.7
umol/l
41.6
46.6
0.48
23
150
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
6201
42872
1.00
0.05
4.7
5.9
ug/l
5.3
4.5
0.34
5241
37748
(3052851) Hemolysis interference index of Serum or Plasma
552
3837
0.99
0.05
3.7
3.6
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
245
1672
1.01
0.05
5.8
6.1
mg/l
12.9
12.4
1.00
215
1503
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
223
1557
0.99
0.05
1.3
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
735
5101
0.99
0.04
2.7
3.2
pmol/l
4.3
4.3
0.22
598
4389
(3005988) Vibrio sp identified in Specimen by Organism specific culture
215
1501
0.99
0.04
1.3
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
165
1124
1.01
0.04
1.2
1.5
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
78
550
0.98
0.04
1.0
1.1
nmol/l
3.1
9.6
1.31
12
124
(3028433) Virus identified in Specimen by Culture
52
349
1.03
0.04
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
153
1070
0.99
0.04
1.2
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
215
1498
0.99
0.03
1.3
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
405
2812
0.99
0.03
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
215
1497
0.99
0.03
1.3
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
42
297
0.98
0.02
1.1
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
24
172
0.96
0.02
1.1
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
156
1067
1.01
0.02
2.6
3.1
mg/l
51.3
40.7
0.26
111
784
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
41
290
0.98
0.02
1.3
1.3
%
31.3
30.7
0.04
26
188
(3000060) B lymphocytes [#/volume] in Blood
21
151
0.96
0.02
2.2
1.8
e6/l
2796.9
1311.5
0.22
13
74
(3000012) Reticulocyte production index
119
830
0.99
0.02
1.7
1.6
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
50
352
0.98
0.02
1.4
1.9
mmol/l
1.8
0.6
1.66
42
334
(3045414) Leukocytes [Presence] in Urine
693
4798
1.00
0.02
2.1
2.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
23
153
1.04
0.02
1.2
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
88
0.94
0.02
1.1
1.0
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
33
222
1.03
0.02
1.0
1.2
mmol/l
0.6
1.6
1.34
20
141
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
60
408
1.02
0.01
1.2
1.4
%
16.3
20.7
0.73
44
345
(3017732) Neutrophils [#/volume] in Blood
966
6678
1.00
0.01
3.4
3.2
e9/l
4.3
4.2
0.60
607
4583
(3023383) Lactate [Moles/volume] in Pleural fluid
76
530
0.99
0.01
1.2
1.3
mmol/l
3.9
3.3
0.77
67
486
(3020650) Glucose [Presence] in Urine
28
198
0.98
0.01
2.4
1.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
16
106
1.04
0.01
1.3
1.4
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
24
170
0.97
0.00
1.1
1.3
ug/l
79.1
109.0
0.62
16
110
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
20
134
1.03
0.00
2.8
5.9
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
97
1.00
0.00
1.1
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
26
181
0.99
0.00
1.0
1.2
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
12
82
1.01
0.00
2.2
1.8
%
6.0
12.7
—
6
44
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
17
121
0.97
0.00
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
42
290
1.00
0.00
2.1
2.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
45
309
1.01
0.00
1.1
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
18
128
0.97
0.00
1.4
1.6
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
65
449
1.00
0.00
4.0
6.6
mmol/l
24.8
24.9
0.08
57
404
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
14
98
0.99
0.00
2.1
1.8
%
76.7
64.3
—
9
62
(3023511) Choriogonadotropin [Units/volume] in Urine
22
152
1.00
0.00
1.5
1.3
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
30
208
1.00
0.00
1.2
1.4
%
76.1
74.1
0.13
23
177
(3005011) Chlamydia sp Ab [Titer] in Serum
14
95
1.02
0.00
1.7
1.9
—
—
—
0
0
(3008343) Lysozyme [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
22.9
—
0
6
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
6
0.00
0.00
0.0
1.8
—
5.7
—
0
6
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
31.0
—
0
6
(3025504) Homovanillate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028468) Fragments [Presence] in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011324) Intrinsic factor Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1.0
—
0
5
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
34.8
—
0
5
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
41
0.84
0.00
1.6
1.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
9
68
0.91
0.00
1.1
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
9
67
0.93
0.00
1.2
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_DEMENTIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_DEMENTIA | 2.556 [2.35, 2.78] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 123209 out of 192688 females with F5_DEMENTIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_DEMENTIA | 2.794 [2.5, 3.12] | < 0.001 |
| Birth year | 0.984 [0.98, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 76869 out of 117357 males with F5_DEMENTIA died.
Mortality risk
Mortality risk for people of age
years, who have F5_DEMENTIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.187% | 0.43% |
| 5 | 1.061% | 2.292% |
| 10 | 2.599% | 5.449% |
| 15 | 4.58% | 10.147% |
| 20 | 7.419% | 16.761% |
Relationships between endpoints
↥Index endpoint: F5_DEMENTIA – Dementia
GWS hits: 44
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data